Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8374407959252483,-2.2487526814423564,0.0,0.0,0.0,8/22,6.28%,ALDH1A2;NR2F2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4;CRABP2
prerank,cation channel activity (GO:0005261),-0.5343661943741262,-1.936849507462893,0.0,0.031759012140090546,0.058,26/94,12.82%,SLC24A3;TRPM3;NALCN;PIEZO2;MCU;ANXA2;PKD1;KCNK5;ANO6;PKD2;TRPC3;ABCC9;TRPM6;ANXA6;KCNQ4;ANO1;CALHM2;CACNA1D;CALHM5;TRPC6;TRPM4;SLC24A5;TMEM175;CACNB2;PSEN1;PANX1
prerank,metalloendopeptidase activity (GO:0004222),-0.5325457277892125,-1.8753747496397355,0.0,0.06417967036643299,0.171,24/76,11.61%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;ADAMTS6;ADAMTSL5;MMP14;MMP16;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ADAM19;ADAM33;IDE;ADAMTS1;MMP19;AFG3L2
prerank,sialyltransferase activity (GO:0008373),0.7910501352000103,1.8525073351913603,0.0,0.3004355718598776,0.234,6/20,2.39%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;ST3GAL1;ST6GALNAC2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8177115134792554,1.8093499419963193,0.003590664272890485,0.2143575986514177,0.42,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8177115134792554,1.8093499419963193,0.003590664272890485,0.2143575986514177,0.42,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,retinoic acid binding (GO:0001972),-0.7718996806653645,-1.793989095947048,0.0,0.16177246808858622,0.441,4/12,17.21%,NR2F2;CYP26B1;RXRA;RARA
prerank,monocarboxylic acid binding (GO:0033293),-0.6911655376411292,-1.7913525957192276,0.0023923444976076554,0.133983332466007,0.453,7/18,22.37%,NR2F2;CYP26B1;RXRA;NR1H4;RARA;PSAP;PYGL
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6932483358429373,1.790603914578268,0.006420545746388443,0.22306587609663156,0.531,5/32,2.87%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.5535499805754932,-1.7784844870250172,0.0,0.13001345594849567,0.497,13/48,10.59%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;PKD2;ABCC9;TRPM6;SLC12A7;CALHM2;CALHM5;TRPC6;TRPM4
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.7010380487727649,1.7708938612415346,0.003305785123966942,0.24356382146767333,0.643,5/30,4.15%,SLC39A10;SLC40A1;SLC39A8;SLC30A1;SLC31A1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7348247777462019,-1.7529405877343918,0.00909090909090909,0.1538327150535636,0.613,4/13,1.89%,BMP6;BMP5;BMP7;BMP4
prerank,BMP receptor binding (GO:0070700),-0.7348259481943026,-1.7127320432081268,0.013729977116704805,0.21214027640451108,0.775,4/12,1.89%,BMP6;BMP5;BMP7;BMP4
prerank,death receptor activity (GO:0005035),0.8331550742605935,1.7095137478721623,0.005405405405405406,0.4781179251170293,0.914,4/11,2.32%,TNFRSF19;FAS;TNFRSF25;TNFRSF11A
prerank,acylglycerol lipase activity (GO:0047372),0.8106675482477286,1.7055184552295175,0.019748653500897665,0.42933721712035067,0.922,2/11,2.92%,ABHD2;LIPE
prerank,cAMP binding (GO:0030552),0.820618751787078,1.7022495704099718,0.010968921389396709,0.3907420836354847,0.932,5/11,8.10%,PDE2A;RAPGEF2;PDE4D;RAPGEF4;PDE4B
prerank,platelet-derived growth factor binding (GO:0048407),-0.7513698258549438,-1.697079866637115,0.011389521640091117,0.2245185719348068,0.833,7/11,2.17%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,cation transmembrane transporter activity (GO:0008324),0.6144474481390911,1.6967365015493967,0.009146341463414634,0.3694319239258027,0.936,5/48,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC38A5
prerank,protein phosphatase 2A binding (GO:0051721),0.7109063720900882,1.689296222274178,0.011419249592169658,0.3643409309578315,0.957,5/23,4.92%,MFHAS1;DAB2IP;CTTNBP2NL;FOXO1;STRN4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7406563312194094,-1.6695433985136552,0.009302325581395349,0.2730282574918409,0.906,3/10,5.61%,SLC6A13;SLC6A12;SLC6A1
prerank,leak channel activity (GO:0022840),-0.6529825539589074,-1.6655232807094347,0.007075471698113208,0.25795174917192865,0.917,5/18,12.82%,KCNK2;NALCN;KCNK5;TMEM175;PANX1
prerank,anion transmembrane transporter activity (GO:0008509),0.7843301172043866,1.6619580740646778,0.02376599634369287,0.44969422932994146,0.983,3/12,1.24%,ABCG2;SLCO2B1;SLC39A8
prerank,protease binding (GO:0002020),-0.4511677458530518,-1.6549403087538788,0.0,0.26077126374402476,0.928,22/99,8.93%,COL1A2;COL3A1;COL1A1;TIMP2;CCBE1;TIMP3;SLC2A13;ANXA2;ATP9A;STIM1;F3;AMFR;ADAMTSL4;FAP;ECM1;LCOR;BCL2;PRKN;SELENOS;BDKRB2;LDLR;DPP4
prerank,metallopeptidase activity (GO:0008237),-0.4390072412493883,-1.6465659277067213,0.0,0.2601795994553572,0.938,27/113,11.61%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;PAPPA;ADAMTS6;ADAMTSL5;MMP14;MMP16;ANPEP;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;ADAM33;IDE;ADAMTS1;MMP19;AFG3L2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5920334886634493,1.6446522864883528,0.010687022900763359,0.4896731394193323,0.99,6/51,3.10%,SLCO1C1;SLC7A5;MFSD2A;SLCO2B1;SLC16A2;SLC22A8
prerank,alanine transmembrane transporter activity (GO:0022858),0.7589869071133687,1.6389203829432362,0.028169014084507043,0.47859456160441527,0.992,2/12,1.98%,SLC6A6;SLC38A5
prerank,calcium channel activity (GO:0005262),-0.4609365753596607,-1.636609172953944,0.0,0.26704508645473457,0.954,24/84,13.30%,SLC24A3;CACNA1C;CACNA2D3;MCU;ANXA2;PKD1;CACNA2D1;PKD2;TRPC3;ANXA6;P2RX4;CACNA1D;TRPC6;CACNB4;ITGAV;TRPM4;SLC24A5;TRPC4;CACNB2;PSEN1;CATSPER3;PANX1;ORAI2;CACNB1
prerank,phospholipid transfer activity (GO:0120014),0.6950090530503313,1.6365712761887805,0.014652014652014652,0.4547443342819361,0.994,12/21,17.57%,CERT1;PLTP;PITPNC1;PRELID2;PITPNA;ABCA3;MTTP;GLTP;PLEKHA3;PITPNB;TRIAP1;C2CD2L
prerank,solute:anion antiporter activity (GO:0140323),-0.664077897063518,-1.6318705631315373,0.034934497816593885,0.2608870518091188,0.958,4/14,8.95%,SLC7A11;SLC26A7;SLC26A2;SLC4A2
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.689800817652136,-1.6279179627271116,0.017582417582417582,0.2545683316854133,0.967,8/12,24.61%,SULF1;SULF2;ARSI;ARSB;GNS;GALNS;ARSG;SGSH
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5124445362234817,1.6224935452480607,0.003937007874015748,0.48907025867312515,0.997,11/134,1.98%,SLCO1C1;SLC6A6;SLC7A5;ABCC4;SLC7A1;ABCG2;SLC1A1;MFSD2A;SLCO2B1;SLC39A8;SLC38A5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6545897991957552,-1.6026624815498243,0.02546296296296296,0.2993753938499712,0.989,8/15,14.18%,HS3ST3A1;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2;NDST2;NDST4;NDST1
prerank,cadherin binding (GO:0045296),0.4566940605059417,1.5986478423547221,0.0,0.5732391095185959,0.998,55/315,9.26%,PROM1;COBLL1;PTPRM;ITGA6;PTPRB;BSG;DOCK9;TJP1;SPTBN1;KDR;DAB2IP;MACF1;ESYT2;WASF2;BMPR2;EPN2;MRTFB;FASN;TJP2;FNBP1L;TRIM25;FLNB;F11R;STK38;PTPRJ;LRRFIP1;CDH2;CD2AP;STXBP6;PPFIBP1;CDH20;TBC1D2;CTNND1;CTNNB1;HSP90AB1;CDH8;EIF4H;EPS8L2;MRE11;BAIAP2;DBNL;STAT1;PKN2;DCHS1;CDH19;PKP4;PKM;CTNNA3;TWF2;SPTAN1;EIF3E;IQGAP1;CLINT1;SLC3A2;CAPG
prerank,glycerophospholipid flippase activity (GO:0140333),0.7539542962424604,1.5968967507597007,0.034545454545454546,0.5480304194933672,0.998,6/11,9.75%,ATP10A;ATP8A1;ATP11A;ABCA3;ATP11C;ATP10B
prerank,phosphatidylcholine transporter activity (GO:0008525),0.6940245085613669,1.5963312663305507,0.03466204506065858,0.520766155682051,0.998,9/17,11.60%,ATP10A;PLTP;ABCG1;PITPNC1;PITPNA;ABCA3;ABCA7;ATP10B;MTTP
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.6855530420242016,1.5842986893536606,0.017953321364452424,0.5503137758799308,0.999,3/20,3.02%,SLC39A10;SLC39A8;SLC30A1
prerank,semaphorin receptor binding (GO:0030215),0.6470777719960201,1.5808408797456541,0.02292768959435626,0.5391261072957101,0.999,7/23,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6411504057434164,-1.580262829420993,0.019417475728155338,0.34207102659222527,0.993,4/15,7.90%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,lipoprotein particle binding (GO:0071813),0.6813088182309432,1.5790794222666464,0.029259896729776247,0.520774130295096,0.999,4/20,2.93%,PLTP;STAB1;SCARF1;SCARB1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4860017078055251,1.5733694926066668,0.00392156862745098,0.5231360656860806,0.999,37/147,10.86%,DOCK4;DOCK9;FGD5;PREX2;RAPGEF2;RASGRF2;DENND3;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;ARHGEF2;KALRN;RAPGEF1;TIAM1;ABR;RIN3;RAPGEF3;DENND5B;CYTH3;EPS8L2;CCDC88A;DENND4C;RAPGEF4;SOS1;RASGRP2;RGL2;ARHGEF5;PREX1;ARHGEF7;FGD6;EIF2B1;EIF2B2;DENND1B;LAMTOR5
prerank,cell adhesion mediator activity (GO:0098631),0.6426461636871489,1.5718830712892118,0.0274442538593482,0.5060266437186218,1.0,7/24,11.16%,BSG;ESAM;ROBO4;DSCAML1;CNTN2;BCAM;PLXNB3
prerank,AMP binding (GO:0016208),-0.6944515929171458,-1.5709207188013194,0.05032822757111598,0.3494013687583317,0.995,4/11,10.34%,PRKAG2;MPPED2;PFKP;PRKAG3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.755474388062715,1.568816652600443,0.038817005545286505,0.4982558167090863,1.0,2/11,1.14%,SGMS1;SGMS2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6878294686902507,-1.5674592707346164,0.0378619153674833,0.3418559916141934,0.995,5/11,11.92%,ITPR1;TRPC3;TRPC6;ITPR2;TRPC4
prerank,peptidoglycan binding (GO:0042834),0.7488370019803191,1.5582512276024114,0.054613935969868174,0.5264354675880504,1.0,3/10,3.20%,PGLYRP1;NOD1;NOD2
prerank,FAD binding (GO:0071949),-0.5606343965027482,-1.5520750356199287,0.026881720430107527,0.3690567348243558,1.0,11/24,20.48%,MICAL3;DDO;MICAL2;PRODH;MTHFR;CRY2;MICAL1;SQOR;SQLE;KMO;AGPS
prerank,phospholipase inhibitor activity (GO:0004859),-0.697129426617336,-1.5505509838062694,0.04339250493096647,0.35602574404771964,1.0,4/10,5.77%,ANXA2;ANXA1;ANXA4;ANXA5
prerank,low-density lipoprotein particle binding (GO:0030169),0.7031640508001713,1.5477504392223511,0.04085257548845471,0.5514426517711081,1.0,4/16,2.93%,PLTP;STAB1;SCARF1;SCARB1
prerank,amyloid-beta binding (GO:0001540),0.5242539011724288,1.545978086989573,0.015492957746478873,0.5387223260551949,1.0,18/79,11.28%,ITM2A;INSR;CACNA1A;APBB2;FZD6;TGFB2;BCHE;FZD4;CLSTN1;RAMP3;EPHA4;ATP1A3;GRIA4;APBA2;PFDN4;PFDN2;AGER;GRIN2B
prerank,glutamate receptor binding (GO:0035254),0.668082804752193,1.5240652668703691,0.04753199268738574,0.613933559887576,1.0,4/17,6.43%,HIP1;SHANK3;HOMER2;HOMER1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5945412136963688,1.5235185573038494,0.056291390728476824,0.5955699509513823,1.0,14/30,22.16%,RPS6KA1;VIL1;XIAP;BIRC3;CST7;SPOCK1;PTTG1;PRDX5;GAS6;CSTB;SERPINB9;UBE2Z;RPS6KA3;SNCA
prerank,pentosyltransferase activity (GO:0016763),-0.514001796054278,-1.5211506971388604,0.020833333333333332,0.4246904857102869,1.0,15/36,16.88%,LARGE1;PARP8;PARP3;LACC1;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;UPP2;SIRT2;QPRT;TIPARP;UMPS
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7235238897645626,1.5183109586947534,0.0641025641025641,0.5996318888525517,1.0,6/12,12.15%,PIK3R6;PIK3R3;PIK3C3;PIK3C2A;IPMK;PIK3CB
prerank,phosphatidylinositol binding (GO:0035091),0.5023200592143297,1.5164128251540503,0.02109704641350211,0.5881004440420347,1.0,18/91,7.28%,MCF2L;HIP1;MYO1E;ESYT2;FES;HIP1R;SCARB1;EPB41;PARD3;SNX13;PITPNC1;PITPNA;PIGU;CCDC88A;ESYT1;PLEKHF2;FCHO2;WDFY3
prerank,SH3 domain binding (GO:0017124),0.5278923886005494,1.514152944093481,0.015942028985507246,0.5800529179522909,1.0,12/62,4.44%,SHANK3;DAB2IP;AFAP1L1;WASF2;ARHGAP27;ELMO1;AFAP1L2;ADAM15;PTPN12;CD2AP;EVL;GRB2
prerank,poly(U) RNA binding (GO:0008266),-0.5562588279764644,-1.5095406260368995,0.06372549019607843,0.4440058767554066,1.0,7/20,16.38%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L
prerank,GTPase activator activity (GO:0005096),0.4341097757262308,1.5079400123916924,0.0011627906976744186,0.5882959039125059,1.0,58/313,8.64%,CHN2;PLCB1;RASGRP3;DOCK4;DOCK9;FGD5;ARHGAP31;PREX2;ARAP3;TBC1D4;SRGAP2;RAPGEF2;RASGRF2;DENND3;RGS3;ARHGAP27;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;TBC1D14;ARHGEF2;TBC1D22A;KALRN;RAPGEF1;SIPA1L2;SIPA1;TIAM1;ABR;RIN3;RALGAPA1;GNAQ;TBC1D12;STARD13;RAPGEF3;DENND5B;TBC1D2;CYTH3;USP6NL;EPS8L2;OCRL;CCDC88A;DENND4C;TBC1D5;RAPGEF4;RAP1GDS1;SOS1;RASGRP2;ARHGAP25;RGL2;JUN;ARHGEF5;IQGAP1;PREX1;ARHGEF7;OPHN1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.690758696969917,-1.506091457817357,0.051224944320712694,0.43732159716904684,1.0,8/10,25.58%,AUH;ECHDC2;ECHDC1;ECHDC3;EHHADH;ECI1;HADHA;ECHS1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.655571725991356,-1.5059941144403457,0.05639913232104121,0.42080691085619976,1.0,4/12,4.30%,GAB2;IRS1;SHC1;FRS2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.7402240624174181,1.5043868675512106,0.06654991243432574,0.5864197375974377,1.0,1/10,0.11%,MECOM
prerank,pre-mRNA binding (GO:0036002),-0.5261727962512117,-1.5016619628771388,0.0412621359223301,0.4181603265111922,1.0,10/28,22.46%,CELF2;DDX5;RNPC3;SRSF6;RBM41;U2AF2;U2AF1;TRA2B;TARBP2;RBM24
prerank,Toll-like receptor binding (GO:0035325),0.7248368298885429,1.4962989618356284,0.07564575645756458,0.6012156470033022,1.0,4/11,11.08%,DAB2IP;TIRAP;TOLLIP;S100A8
prerank,protein tyrosine kinase activity (GO:0004713),0.4823267961593514,1.4946910331119712,0.011857707509881422,0.5906556644090236,1.0,21/108,6.86%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FES;FLT4;PTK2;JAK3;ZAP70;MERTK;LYN;CAMKK2;EPHA4;FYN;RET;YES1;AATK;EPHB4;HCK
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6340680320337007,-1.4941546195161375,0.04899777282850779,0.42566292052494126,1.0,4/13,7.90%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5486543620105838,1.4930204363923811,0.03189792663476874,0.580856589217294,1.0,8/42,6.91%,BSG;ESAM;ROBO4;CD200;DSCAML1;STXBP6;BAIAP2;CNTN2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.5328547610210806,-1.488687461699016,0.036585365853658534,0.4259745949436498,1.0,11/27,19.77%,ITPR1;SLC41A1;SLC12A2;CNNM2;SLC9B2;ITPR2;ATP2A3;ZDHHC13;MAGT1;ATP2B3;TUSC3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5904123287388339,1.4825549356582028,0.06678082191780822,0.6078783102875134,1.0,4/26,1.67%,SLC6A6;ABCG2;SLC16A4;SLC16A2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6856619586640361,1.4814016713316054,0.07514450867052024,0.5972384007618406,1.0,2/11,4.52%,LEF1;GATA2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.733481527969219,1.4803547240667285,0.07198443579766536,0.5864271258418764,1.0,3/11,2.56%,DAB2IP;MAP4K2;STK38
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.606942430820262,1.479750663418885,0.06379310344827586,0.5743787011730118,1.0,5/24,7.17%,CERT1;DAB2IP;OSBP;SNX3;PLEKHA5
prerank,estrogen receptor binding (GO:0030331),0.5664233075424331,1.474621436757587,0.0707070707070707,0.5813492909854296,1.0,5/32,9.84%,LEF1;NCOA1;CTNNB1;TACC1;SRARP
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5273530556526539,-1.4743337467426472,0.06329113924050633,0.4539553797774193,1.0,8/23,19.38%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L;U2AF2
prerank,cyclic nucleotide binding (GO:0030551),0.6207076350902694,1.4714301671767482,0.08261617900172118,0.5794665404823244,1.0,6/21,8.10%,PDE2A;RAPGEF2;CNGA2;PDE4D;RAPGEF4;PDE4B
prerank,solute:sodium symporter activity (GO:0015370),-0.5227595805876174,-1.4672697779124966,0.05025125628140704,0.4596092523015523,1.0,7/27,15.91%,SLC4A10;SLC5A6;SLC20A2;SLC4A7;SLC5A3;SLC5A7;SLC20A1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.5420026502847496,-1.4585283849055704,0.05938242280285035,0.47074051392802185,1.0,4/21,4.69%,FGF1;FRS2;KL;FGF2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5114855966770342,1.4580445006619975,0.04227405247813411,0.6167424360914955,1.0,12/60,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;ACVRL1;MERTK;EPHA4;RET;EPHB4
prerank,hexose transmembrane transporter activity (GO:0015149),0.6849012140455819,1.4578055298394548,0.09363295880149813,0.6038185607012122,1.0,1/12,0.45%,SLC2A1
prerank,protein tyrosine kinase binding (GO:1990782),0.500833920922589,1.456247417196311,0.041726618705035974,0.5961529465755256,1.0,10/71,5.52%,GRB14;DOCK4;BMPR2;TJP2;NEDD9;DUSP3;ELMO2;HYAL2;CD4;EPHA4
prerank,fibroblast growth factor binding (GO:0017134),-0.5555999362612924,-1.453287029340062,0.05411764705882353,0.47307695167009883,1.0,5/21,10.36%,FGFR2;THBS1;KL;API5;ITGAV
prerank,GTPase regulator activity (GO:0030695),0.4359311989067548,1.4531187158726782,0.007361963190184049,0.5950133662566082,1.0,32/212,6.47%,CHN2;PLCB1;RASGRP3;ARHGAP31;RGS12;PREX2;ARAP3;TBC1D4;SRGAP2;RAPGEF2;SH3BP4;RGS3;ARHGAP27;DOCK1;ARL2BP;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;ABR;RALGAPA1;GNAQ;TBC1D12;STARD13;TBC1D2;USP6NL;OCRL;CCDC88A;TBC1D5;RAP1GDS1;SOS1;ARHGAP25
prerank,potassium ion leak channel activity (GO:0022841),-0.5868413804057859,-1.4506758916674904,0.07674943566591422,0.4671902475203577,1.0,2/15,3.08%,KCNK2;KCNK5
prerank,mRNA 3'-UTR binding (GO:0003730),-0.40727822393694907,-1.4484134008404892,0.013793103448275862,0.4606758135963492,1.0,18/79,16.38%,CELF2;RBMS3;CPEB1;CPEB2;DDX5;RBMS1;AUH;CSDC2;YBX3;FXR2;IGF2BP2;RNF20;FMR1;PCBP4;HNRNPA2B1;PABPC4;TUT1;PABPC4L
prerank,chemorepellent activity (GO:0045499),0.5890021452133178,1.4475971159726628,0.0657672849915683,0.6035506137028979,1.0,6/25,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D
prerank,phosphatidylglycerol binding (GO:1901611),0.6798038636730093,1.4416451148796463,0.0918918918918919,0.6131133139743691,1.0,3/13,5.12%,PLTP;PITPNC1;PITPNA
prerank,fatty acid synthase activity (GO:0004312),0.7056939731768521,1.4397407972972314,0.09357798165137615,0.6082061927986084,1.0,3/10,12.19%,ELOVL7;ELOVL5;ELOVL6
prerank,Hsp90 protein binding (GO:0051879),0.5529422762106811,1.4390149524966682,0.06482982171799027,0.5988024352768877,1.0,5/33,4.06%,KDR;UNC45B;NOD2;CYP2E1;FKBP6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5175272992873939,1.438621762857339,0.057902973395931145,0.5888521749972929,1.0,6/55,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC16A4;SLC16A2;SLC38A5
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6190594191092136,-1.436586028580084,0.07066381156316917,0.48267081992075117,1.0,3/11,4.66%,KCNK2;KCNT2;PKD2
prerank,metalloaminopeptidase activity (GO:0070006),-0.5769434359609218,-1.433035462051895,0.0625,0.4809719988884828,1.0,5/16,8.24%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,insulin-like growth factor I binding (GO:0031994),0.6614822028325456,1.4293339303338641,0.12149532710280374,0.6105779029039704,1.0,3/13,0.95%,IGF1R;ITGA6;INSR
prerank,diacylglycerol kinase activity (GO:0004143),0.6899062567176839,1.4255708230366002,0.09514925373134328,0.6130962255178439,1.0,4/11,11.93%,DGKH;DGKI;DGKE;DGKZ
prerank,actin monomer binding (GO:0003785),0.594504057950802,1.4244972639706335,0.10210696920583469,0.6061509175274479,1.0,6/22,8.14%,NOS3;MRTFA;MTSS1;TMSB4X;TMSB10;TWF2
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.4405509397753479,-1.4240643047737902,0.03289473684210526,0.4947197433861803,1.0,14/55,12.82%,SLC24A3;ITPR1;MCU;ANXA2;PKD1;PKD2;TRPC3;ANXA6;CACNA1D;ITPR2;SLC24A5;CACNB2;PSEN1;PANX1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6672424100870974,1.4237597252550263,0.12773722627737227,0.5980541116615851,1.0,5/12,12.00%,CNOT6L;NOCT;PAN3;PAN2;CNOT6
prerank,alkali metal ion binding (GO:0031420),-0.6145148695939626,-1.4214633249311324,0.08125,0.4896689996791846,1.0,3/13,8.71%,ATP1A2;HDAC4;TDG
prerank,phosphate ion binding (GO:0042301),0.7001842456234435,1.42089569372283,0.1167608286252354,0.5972926410449002,1.0,3/10,11.08%,PDE2A;ADSS2;PNP
prerank,ATPase binding (GO:0051117),-0.410971951720979,-1.4188003269222809,0.02622950819672131,0.48591288574338537,1.0,21/71,13.91%,ANK2;EGFR;SLC2A13;PTPN3;SNTA1;ABCA1;PKD2;AR;ATP6V0A4;ATP1B3;TMTC4;ATP1B2;SELENOS;EZR;TOR1AIP1;ESR1;PGR;PSEN1;SYVN1;NKD2;ATP5IF1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6142054511605,1.4185958178093554,0.09386281588447654,0.595223467763907,1.0,1/17,0.45%,SLC2A1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5275762538762979,-1.414306110611878,0.07960199004975124,0.4865277324723171,1.0,3/22,2.18%,RBMS3;CPEB1;CPEB2
prerank,frizzled binding (GO:0005109),-0.4733708163490014,-1.4122358013622893,0.05337078651685393,0.4806622514446294,1.0,14/34,20.28%,WNT4;WNT5B;RNF43;WNT6;WNT9A;FZD7;MYOC;DVL2;WNT11;LRP6;SFRP1;RYK;WNT16;DVL3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6825942187276697,1.40873839597761,0.13059701492537312,0.6199453368200933,1.0,3/10,5.22%,SLCO1C1;SLCO2B1;SLC22A7
prerank,poly-purine tract binding (GO:0070717),-0.49296309068448607,-1.4040086458432568,0.08374384236453201,0.4946650786238522,1.0,9/27,16.94%,RBMS3;RBMS1;DDX1;PATL1;FMR1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.47681050234849276,-1.4033495231112594,0.05181347150259067,0.48491139416737694,1.0,8/31,12.60%,KCNK5;SLC12A2;PKD2;ABCC9;KCNQ4;SLC12A7;TMEM175;SLC12A4
prerank,protein kinase C activity (GO:0004697),0.6288670744945182,1.4026622825971624,0.1223021582733813,0.6309314475931377,1.0,4/14,5.38%,PRKCH;PRKD1;PRKD3;PKN1
prerank,glutamate receptor activity (GO:0008066),0.6017988496432147,1.4023743376681705,0.13620071684587814,0.6215931103516827,1.0,12/19,24.75%,GRID2;GRIA4;GRIK5;GRIK2;GRIK1;GRM7;GRM8;GRIA2;GRM2;GRM3;GRIK3;GRID1
prerank,clathrin adaptor activity (GO:0035615),0.6273917119439165,1.402327662701941,0.12190812720848057,0.6117294797401522,1.0,4/15,12.31%,HIP1;HIP1R;AP2M1;AP2B1
prerank,peptidase inhibitor activity (GO:0030414),-0.48823331141064974,-1.3947511902164218,0.07387862796833773,0.49718292407920917,1.0,6/33,10.14%,TIMP2;TFPI;GPC3;ITIH2;SERPIND1;RENBP
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5007114040268039,1.3797388505659602,0.08955223880597014,0.6831691503448531,1.0,6/47,2.87%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5;SLC43A2
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4596375062615692,-1.3797359911172302,0.09798994974874371,0.5301726938304654,1.0,11/37,13.30%,CACNA1C;CACNA2D3;CACNA2D1;PKD2;CACNA1G;CACNA1D;CACNB4;ITGAV;CACNB2;CATSPER3;CACNB1
prerank,insulin-like growth factor binding (GO:0005520),0.6236659247628097,1.3779070490198932,0.15063520871143377,0.6791671406295176,1.0,3/15,0.95%,IGF1R;ITGA6;INSR
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.44812638032600766,1.3756379723064955,0.05874125874125874,0.6768804931838674,1.0,19/100,10.91%,CERT1;HIP1;ARAP3;MYO10;DAB2IP;ARAP2;HIP1R;PARD3;OSBP;SNX13;SNX3;CYTH3;TECPR1;PIRT;PLEKHA5;IQGAP1;CLVS2;DENND1B;FERMT2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6150971537737855,1.3747355289681815,0.14028776978417265,0.670126308227234,1.0,4/15,9.66%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6241534781850604,1.368295416361253,0.1417624521072797,0.6832798427348817,1.0,2/12,6.20%,ENTPD1;ENTPD5
prerank,poly(A) binding (GO:0008143),-0.5110064446876631,-1.3609602918631318,0.11594202898550725,0.5756743277680508,1.0,7/21,16.94%,RBMS3;RBMS1;DDX1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6119723022465764,-1.3565746785096195,0.13203463203463203,0.5765211819675422,1.0,4/10,9.40%,ANO6;CLCN2;ANO1;CLCN6
prerank,actin binding (GO:0003779),0.4172369510806656,1.3564140592898295,0.04064039408866995,0.7168813578979915,1.0,32/170,8.14%,FLII;PARVB;UTRN;ABLIM1;SYNE1;MACF1;MYRIP;NOS3;KLHL2;SLC6A2;MRTFA;FLNB;CORO2B;PTK2;MTSS1;NOD2;VASH1;SSH2;MYO6;TMSB4X;EPS8;EPS8L2;CCDC88A;ACTN4;DBNL;PRICKLE4;PARVG;SORBS1;MSRB2;FHL3;TMSB10;TWF2
prerank,endopeptidase activity (GO:0004175),-0.32554086897316836,-1.3562190219276506,0.0,0.5656871492733347,1.0,62/257,18.87%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;ADAMTS6;ADAMTSL5;PCSK5;MMP14;HTRA3;MMP16;F3;USP11;USP24;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;FAP;BACE2;CTSL;ADAMTS15;USP40;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;KLK2;DPP4;USP2;ADAM33;IDE;RHBDL3;ADAMTS1;MMP19;AFG3L2;PSEN1;CTSH;USP42;USP9X;HTRA4;HTRA2;ADAMTS14;CTSZ;CASP3;MASP1;ACE2;ADAMTS9;NRDC;ZMPSTE24;PRSS12;RHBDF1;PARL;SFRP1;CASP6;CASP4;MBTPS1;PCSK6;GZMM;USP16
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4975166970119208,-1.3524142468177274,0.10256410256410256,0.5656677049801878,1.0,10/25,16.33%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;SIRT2;TIPARP
prerank,carboxylic ester hydrolase activity (GO:0052689),0.44268987697845424,1.3507889575737673,0.07005494505494506,0.7265732355376247,1.0,11/85,10.76%,ABHD2;BCHE;LIPE;PLA2G4B;PNPLA6;NOTUM;GDPD1;ENPP2;LYPLA1;PTRH2;LIPC
prerank,alpha-actinin binding (GO:0051393),-0.4985636772215193,-1.3468133747428983,0.11990407673860912,0.5726546876510078,1.0,8/24,7.86%,CACNA1C;PALLD;PDLIM7;DAG1;PKD2;PDLIM2;PDLIM4;CACNA1D
prerank,motor activity (GO:0003774),0.47514535083085563,1.3466202626398338,0.09654178674351585,0.7317680371641042,1.0,12/60,12.40%,MYO1E;STARD9;KIFC3;MYO6;DNAH3;KIF26A;KIF2A;KIF1A;PIN1;KIF3B;KIF23;DNAH8
prerank,cGMP binding (GO:0030553),0.630602508933607,1.3461091714821443,0.15769944341372913,0.7233861347975715,1.0,3/11,3.81%,PDE2A;RAPGEF2;CNGA2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5853226502608463,1.3414847005007373,0.13693693693693693,0.7309231269119794,1.0,9/18,22.16%,RPS6KA1;VIL1;XIAP;BIRC3;PRDX5;GAS6;SERPINB9;RPS6KA3;SNCA
prerank,phospholipase binding (GO:0043274),-0.5535642000741685,-1.3398630381161434,0.1288981288981289,0.5843161999211972,1.0,3/13,9.06%,ARHGAP6;PRKN;PDPK1
prerank,MAP kinase phosphatase activity (GO:0033549),0.6357405949404905,1.3394216046560254,0.17481203007518797,0.7283707864621407,1.0,5/12,14.43%,DUSP7;DUSP3;DUSP1;DUSP16;DUSP8
prerank,ribosomal large subunit binding (GO:0043023),-0.5864476077299838,-1.3389719033444138,0.13495575221238937,0.5756695467044006,1.0,1/11,2.18%,CPEB2
prerank,kinase inhibitor activity (GO:0019210),-0.4427405814124355,-1.3327707500233168,0.10552763819095477,0.5843437685081243,1.0,15/33,28.77%,PARVA;GMFB;QARS1;DUS2;LRP6;DNAJC3;CDKN1C;MAPK8IP1;SMCR8;RHOH;SOCS3;TAOK3;TRIB1;AHSG;DUSP19
prerank,metalloexopeptidase activity (GO:0008235),-0.4132857090978848,-1.3314271487107185,0.07807807807807808,0.5780320658429093,1.0,14/51,15.77%,CPQ;AEBP1;MMP14;MMP16;ANPEP;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;AGBL1;PEPD;ACE2;ZMPSTE24
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4718049049340295,1.3297498528675327,0.10979228486646884,0.7552439185762566,1.0,11/60,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;MERTK;EPHA4;RET;EPHB4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5129577382760506,-1.3272899087420391,0.11724137931034483,0.5697643389584337,1.0,4/17,7.23%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.5129577382760506,-1.3272899087420391,0.11724137931034483,0.5697643389584337,1.0,4/17,7.23%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,transcription coactivator binding (GO:0001223),-0.508397871672309,-1.3256815265545414,0.1362530413625304,0.5648689384464057,1.0,9/20,12.24%,SMAD3;THRB;CCNT2;RORA;AR;MED25;VGLL4;ESR1;PGR
prerank,lipase activator activity (GO:0060229),-0.5886325773104704,-1.3247624842124732,0.16129032258064516,0.5583564035837,1.0,2/10,9.06%,ARHGAP6;PDPK1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6078492663336066,1.3244470806734896,0.16226415094339622,0.7644929782403656,1.0,2/12,5.11%,TENT4A;MTPAP
prerank,muscle alpha-actinin binding (GO:0051371),-0.5407723898500472,-1.3191241408618486,0.14446952595936793,0.5651780868763614,1.0,5/15,7.75%,PALLD;PDLIM7;PKD2;PDLIM2;PDLIM4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5521275239369291,1.3169348785599637,0.16751269035532995,0.7834937697583264,1.0,9/22,17.33%,DUSP23;DUSP7;DUSP3;DUSP12;DUSP1;DUSP16;DUSP8;MTMR2;PPM1F
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.565999086009826,1.3165646087958618,0.18118466898954705,0.7748453019109506,1.0,4/18,9.66%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6266876832766725,1.3162301462712198,0.18504672897196262,0.7661094200359654,1.0,5/12,13.45%,DAB2IP;CCDC88A;GREM1;PGF;CDH5
prerank,MHC class II protein complex binding (GO:0023026),0.6218874971164968,1.3160996032001004,0.19141323792486584,0.7569587495732085,1.0,4/11,10.71%,HSP90AB1;CD4;PKM;HSPA8
prerank,double-stranded RNA binding (GO:0003725),0.4500301522298541,1.315945454593163,0.08260869565217391,0.7481247659808423,1.0,19/70,16.71%,TFRC;LRRFIP1;IFIH1;ADAR;HSP90AB1;EIF4H;TLR3;ACTN1;TLR7;MSN;SLC3A2;OASL;TLR8;ADAD1;RFTN1;ELAVL1;TUBB4B;MRPL44;EIF4A1
prerank,active ion transmembrane transporter activity (GO:0022853),0.5067468616239618,1.3146105137110322,0.15048543689320387,0.7438382342554953,1.0,4/37,5.22%,SLCO1C1;SLCO2B1;SLC22A8;SLC22A7
prerank,histone demethylase activity (GO:0032452),-0.47344204885069596,-1.3128734998613103,0.13691931540342298,0.5739888264806631,1.0,13/27,23.81%,KDM7A;KDM2A;KDM3B;FBXL19;KDM5B;KDM6B;KDM2B;KDM1A;PHF8;RIOX2;PHF2;KDM4D;HR
prerank,vinculin binding (GO:0017166),0.6129220620637472,1.3123673888108196,0.18809980806142035,0.7427686852050878,1.0,5/11,9.38%,UTRN;CORO2B;PXN;ACTN1;SYNM
prerank,pseudouridine synthase activity (GO:0009982),-0.541900415876985,-1.310573060580244,0.1412037037037037,0.5713260596229696,1.0,6/13,28.26%,PUS7;PUS10;RPUSD4;RPUSD1;RPUSD2;RPUSD3
prerank,"DNA binding, bending (GO:0008301)",0.5909509602191907,1.3105115452370195,0.17801047120418848,0.7404295622393453,1.0,2/14,4.35%,LEF1;HHEX
prerank,mannosyltransferase activity (GO:0000030),0.5628130495781499,1.3095566935923393,0.14878892733564014,0.7348924905551617,1.0,1/21,0.08%,TMTC2
prerank,store-operated calcium channel activity (GO:0015279),-0.5803908346883683,-1.3073279616420284,0.19787234042553192,0.5717409859128503,1.0,4/10,13.12%,TRPC3;TRPC6;TRPC4;ORAI2
prerank,symporter activity (GO:0015293),0.6373232770478158,1.3052267766059096,0.19005328596802842,0.7404912318266611,1.0,1/10,0.46%,MFSD2A
prerank,death domain binding (GO:0070513),0.6337626463397683,1.304596038638283,0.19960474308300397,0.7338787874178515,1.0,4/11,8.17%,BCL2L1;CRADD;MCL1;IRGM
prerank,phosphatidic acid binding (GO:0070300),0.5590416827753103,1.3034332146303214,0.18760757314974183,0.7292547141189556,1.0,3/19,4.75%,PLTP;RAPGEF2;PITPNC1
prerank,MHC class I protein binding (GO:0042288),0.6343534638820874,1.3032326520168942,0.170018281535649,0.7215614749206866,1.0,7/13,20.17%,PILRA;TUBB;TAP2;CD8B;ATP5F1A;TUBB4B;TAP1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.47723521632544796,-1.3004045723331794,0.12679425837320574,0.5823467689925881,1.0,10/24,21.06%,CAMK1D;CAMK2D;MAPKAPK3;PHKA2;PTK2B;EEF2K;CAMK1;PHKG2;CAMKK1;PHKA1
prerank,manganese ion binding (GO:0030145),-0.40203192697998225,-1.2975867463193165,0.09831460674157304,0.5818159411529569,1.0,16/48,23.55%,MPPED2;LARGE1;ME1;ADCY2;TDP2;SOD2;B4GALT1;FAM20C;ABL1;DYRK2;PPM1M;PRIMPOL;XPNPEP3;WRN;ATP13A2;GALNT1
prerank,adenylyltransferase activity (GO:0070566),0.5501632602747826,1.2956010097882456,0.18085106382978725,0.7385514939069413,1.0,5/21,10.15%,TENT4A;MTPAP;GPHN;FICD;OASL
prerank,CARD domain binding (GO:0050700),0.6004621318566146,1.291308136209397,0.1935483870967742,0.7448256685640979,1.0,6/14,15.35%,NOD1;NOD2;CARD10;IRGM;BCL10;CARD11
prerank,sterol transfer activity (GO:0120015),0.5743304911386872,1.2877041784971803,0.1692573402417962,0.7493829758898222,1.0,3/17,4.02%,PLTP;OSBP;ABCG1
prerank,transcription corepressor binding (GO:0001222),-0.4668175675885328,-1.2834224662819378,0.15789473684210525,0.6133910341886523,1.0,7/27,6.99%,PER3;USP11;NEK6;EHMT2;RORA;PER2;LCOR
prerank,protein phosphorylated amino acid binding (GO:0045309),0.47255286033039223,1.2823078160259131,0.15323854660347552,0.7594331486732852,1.0,14/42,11.86%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;FBXW7;YES1;HCK;PIN1;SHC3;PTPN5;SHB;SHF;SYK
prerank,MHC protein binding (GO:0042287),0.5674176613327362,1.2822374728673507,0.19015280135823429,0.7514724828126035,1.0,8/20,14.92%,PILRA;CD4;TUBB;TAP2;CD8B;KIR3DL2;ATP5F1A;TUBB4B
prerank,cardiolipin binding (GO:1901612),-0.594857203109701,-1.2813966380544635,0.1568627450980392,0.6105018313160876,1.0,3/10,18.56%,GSDME;GSDMD;PLEKHN1
prerank,protein phosphatase binding (GO:0019903),0.4105454844483817,1.2809583280957524,0.1102257636122178,0.7479997002941292,1.0,15/117,5.16%,MFHAS1;PPP1R16B;DAB2IP;ITGA1;FLT4;CTTNBP2NL;PTK2;FOXO1;JAK3;PXN;PPP1R9B;SNX3;CTNNB1;STRN4;KCNQ1
prerank,myosin II binding (GO:0045159),0.6284291136918234,1.2774848620806611,0.21178637200736647,0.7514538311539773,1.0,2/10,1.44%,SHROOM4;SHROOM1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5855410289205923,-1.2772813716991085,0.20689655172413793,0.6131999706129431,1.0,9/10,41.22%,DSE;RENBP;GALE;FUOM;DSEL;GFUS;GLCE;GALM;GNE
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5288981785264176,-1.2758312080795498,0.185589519650655,0.6088870026785838,1.0,3/14,2.07%,FHIT;ENPP1;NUDT4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6024648050858248,1.2707092388634913,0.21575984990619138,0.7660248814697904,1.0,4/13,2.62%,PDGFB;PDGFD;IL1R1;PTPRJ
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5158216325770665,1.26888381262897,0.16887417218543047,0.7642911892895731,1.0,7/27,13.17%,RNF144B;DCUN1D3;FOXL2;RNF125;TOLLIP;UBE3D;DCUN1D1
prerank,hexosyltransferase activity (GO:0016758),0.4095206351830345,1.264383289674395,0.1279229711141678,0.7722717803582636,1.0,10/101,7.21%,TMTC2;CSGALNACT1;GBE1;B4GALT5;B4GALT4;MFNG;B3GNT2;FUT9;PIGM;GCNT7
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5602663114406529,-1.2629661160269632,0.21017699115044247,0.6373778530168619,1.0,5/10,11.17%,SLC24A3;SLC8A3;SLC8B1;SLC8A1;SLC24A5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.5658512085295662,-1.2617924855845855,0.20430107526881722,0.6318953097679548,1.0,5/11,12.49%,AMFR;UBR5;UBE4B;PPIL2;PRPF19
prerank,phospholipase activator activity (GO:0016004),-0.5600331407989754,-1.2615983466590972,0.1958762886597938,0.623766847813966,1.0,2/10,9.06%,ARHGAP6;PDPK1
prerank,transmitter-gated ion channel activity (GO:0022824),0.4935655339159238,1.2615180601965348,0.1791044776119403,0.7737477051700202,1.0,17/29,25.86%,GRID2;CHRNB1;GABRB1;GRIA4;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GRIA2;GRIK3;GABRA2;GRID1;GABRG2
prerank,nuclear receptor coactivator activity (GO:0030374),0.4478600500484734,1.260217627628351,0.16838995568685378,0.7707428419760459,1.0,14/52,13.23%,ETS1;NCOA1;PKN1;ACTN4;ACTN1;BUD31;NCOA2;TACC1;HMGA1;CNOT9;HELZ2;PRKCB;CNOT6;PSMC3IP
prerank,sulfotransferase activity (GO:0008146),-0.4320014365132419,-1.252836097556781,0.17066666666666666,0.6395715788126197,1.0,9/33,15.23%,UST;HS3ST3A1;HS2ST1;CHST15;HS6ST1;CHST8;CHST3;CHST1;GAL3ST2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4846400807267859,1.252247042483443,0.1650485436893204,0.7900423877647758,1.0,7/38,7.17%,HIP1;DAB2IP;PARD3;SNX13;SNX3;TECPR1;PLEKHA5
prerank,epidermal growth factor receptor binding (GO:0005154),0.5058872793505864,1.251555734521293,0.1905564924114671,0.7846709633722438,1.0,6/25,12.18%,HIP1;GRB2;CCDC88A;TGFA;CNOT9;TNK2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4501442423258172,1.2503492019980265,0.1628614916286149,0.7808281198570141,1.0,6/53,5.02%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC43A2;SLC1A2
prerank,R-SMAD binding (GO:0070412),-0.4784942183352495,-1.2470397343356867,0.19523809523809524,0.6480421062487479,1.0,4/18,2.35%,LDLRAD4;SMAD3;DDX5;SMAD6
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5110432285229152,1.245088041571761,0.22984562607204118,0.7913486102497748,1.0,4/25,6.22%,HIP1;ARAP3;HIP1R;PLEKHA1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5762587387754201,1.2427210132342623,0.25321100917431194,0.7918982144465231,1.0,2/13,1.98%,SLC7A1;SLC38A5
prerank,protein homodimerization activity (GO:0042803),0.3466253584253356,1.2420927510308744,0.03171247357293869,0.7865129131178699,1.0,101/589,12.47%,TFRC;ABCG2;HIP1;PECAM1;PDGFB;SRGAP2;CADM1;BCL2L1;DAB2IP;SYNE1;RASIP1;TGFB2;PDE2A;ZHX3;XDH;TBX1;TPD52;IL6R;FLT4;HIP1R;GCH1;TPD52L1;TRIM14;B2M;F11R;FZD4;NOD1;LRRFIP1;TBC1D22A;KLHL7;DEFA6;GBP4;STK10;DSCAML1;GBP5;VIL1;ZBTB16;ABCG1;IKBKB;HHEX;SARS1;NOS2;HSP90AB1;MTPAP;CD4;CAT;ACOX1;INPP5F;CCDC88A;GSTA4;TPST2;ACTN4;ADAM10;TOX3;MCL1;STAT1;ACTN1;YARS2;FICD;BST2;ACSL6;KCNH2;ST6GAL1;SHMT2;KCNN2;MKLN1;CST7;TERF2;CPOX;FOXP3;PDXK;PRDM9;CAV2;IRAK2;GREM1;RAB11FIP4;BNIP3L;SNRPC;GLB1;CBS;HPGDS;BANF1;COQ9;CNOT9;PDCD10;TIMM10;HSPB1;HOOK1;ABCD1;TPM4;RBPMS;MMAA;SLK;SH3GLB1;MID1;PIP4K2A;CEACAM1;NAA60;GDF15;PANK3;TERF1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.4429872497224173,-1.241439684109353,0.17922077922077922,0.6562073554228959,1.0,8/27,10.27%,SLC41A1;SLC8A3;SLC9A2;SLC8B1;SLC9B2;SLC8A1;SLC9A9;SLC9A1
prerank,GTPase binding (GO:0051020),0.3750782287233206,1.2378055826565832,0.10037174721189591,0.7939244518276339,1.0,36/194,13.05%,DOCK4;FGD5;SPTBN1;SRGAP2;RASIP1;SH3BP4;CAV1;FNBP1L;UNC13B;ARHGEF2;RIN3;YBX1;PEX5L;EPS8;USP6NL;PKN1;OCRL;RAPGEF4;NCKAP1;UNC13D;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;BICDL1;CYFIP1;KIF3B;EXOC4;EXOC2;TBC1D30;GNB1;CYRIB;RANBP9;TMEM127;FGD2
prerank,PDZ domain binding (GO:0030165),0.435759448506966,1.237061757892309,0.18072289156626506,0.7891783397572854,1.0,16/61,10.76%,DOCK4;USHBP1;CADM1;RAPGEF2;F11R;FZD4;ACOX1;GRID2;PLEKHA1;ATP2B1;SLC9A3;TMEM88;TMEM88B;CLCN3;ADAM17;CRIPT
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.522170913364044,1.2355373688909554,0.23620689655172414,0.7867317187201802,1.0,5/23,10.68%,HIP1;HIP1R;SNX3;PLEKHA5;CLVS2
prerank,adenylate cyclase binding (GO:0008179),-0.540147627448613,-1.2331245947102303,0.22857142857142856,0.6711050135244218,1.0,3/10,4.15%,ADCY5;AKAP12;ADCY2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.36183293697716307,1.2327782273552217,0.08960573476702509,0.7889425328660922,1.0,41/248,13.02%,DNM3;MYO1E;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MYO6;MTG1;KIF26A;GNA12;RHOB;EFTUD2;TBC1D24;ABCA3;KIF2A;ATP2B1;KIF1A;RALB;DNM2;RAB11A;RAP1B;PIN1;IRGM;GTPBP1;GPN3;DNA2;GFM1;RAB3B;ABCD1;RAC1;HRAS;MMAA;RAB4A;RND1;GNB1;GPN2;RAB1A
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5952189330992194,1.2326958365324887,0.24084778420038536,0.7821427194374342,1.0,3/10,13.53%,SHANK3;SHISA6;IGSF11
prerank,phosphotyrosine residue binding (GO:0001784),0.46380855568029833,1.230916180727662,0.20880913539967375,0.7813944528742123,1.0,12/37,11.86%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;YES1;HCK;SHC3;PTPN5;SHB;SHF;SYK
prerank,5'-3' exonuclease activity (GO:0008409),0.5573457089262808,1.2297766054630455,0.25,0.7780629524169399,1.0,9/14,21.81%,MRE11;DCP2;DXO;FAN1;TRIR;EXOG;XRN1;XRN2;DCLRE1C
prerank,lysine N-methyltransferase activity (GO:0016278),-0.46060979007379077,-1.226481261871326,0.2200488997555012,0.6822903034235768,1.0,11/20,28.74%,EHMT2;SETD7;SETD4;EEF2KMT;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;ANTKMT;METTL21C
prerank,disordered domain specific binding (GO:0097718),0.5112496305963995,1.2259525912848444,0.2096,0.7840093914491614,1.0,4/23,9.03%,CALM1;HSP90AB1;FYN;DFFB
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.41658921206060584,1.2248118643110009,0.1908177905308465,0.7809490013911838,1.0,14/72,10.17%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;KCNQ1;SYT7;FCHO2;TWF2;CAPG;AMER2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5083468975010438,1.2220153379834655,0.238013698630137,0.7830173553755477,1.0,6/23,11.57%,PLCB1;PLCB4;PLCG1;PLCH2;CHRM3;PLCH1
prerank,LRR domain binding (GO:0030275),-0.5145064496470534,-1.2198942396817223,0.20833333333333334,0.6935068900975543,1.0,2/14,0.50%,ROBO1;PAWR
prerank,growth factor receptor binding (GO:0070851),0.4021181465382021,1.2195014073613677,0.16407355021216408,0.7847841234921954,1.0,17/95,12.20%,HIP1;PDGFB;PDGFD;IL1R1;IL6R;PTPRJ;GRB2;FGF16;CCDC88A;FYN;TGFA;PGF;ADAM17;CNOT9;CNTF;TNK2;IL27RA
prerank,cytokine activity (GO:0005125),-0.32317650274553644,-1.219267250050509,0.08755760368663594,0.6865625053227644,1.0,14/131,4.69%,BMP6;IL34;WNT4;BMP5;BMP7;WNT5B;BMP4;WNT6;IL18;WNT9A;IL16;CXCL16;TNFRSF11B;FGF2
prerank,FMN binding (GO:0010181),0.5716440801924247,1.2177367391745326,0.2709551656920078,0.7841962791024236,1.0,2/11,4.51%,NOS3;NOS2
prerank,protein kinase binding (GO:0019901),0.3438228869863637,1.2173853185721877,0.06557377049180328,0.7787294075587834,1.0,90/479,12.53%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;BMPR2;MAP4K2;CAV1;TJP2;TIRAP;GCH1;NEDD9;TRIM14;STK38;TBC1D14;PTPRJ;RGCC;PTK2;IFNAR2;DUSP7;ACVRL1;NOD2;MAP3K1;PRKD2;HDAC9;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;CALM1;GRB2;HINT1;CEP68;KCNQ1;CD4;RHOB;PKN1;EPHA4;CCDC88A;TSKS;ADAM10;RFFL;ADCY4;CDKN2B;IRF5;PTPRR;SPAG9;PRKAR2B;LRBA;PIN1;TWF2;IRGM;FAM83G;ACSL3;IQGAP1;RPS7;PTN;CAV2;ARHGEF7;SHC3;CDK5RAP2;MSN;CAVIN2;PPP1CB;CCND3;PRKAR2A;TRIB2;GRB7;DCX;PDCD10;SMAD1;NBEAL2;PRKAB1;HSPB1;FERMT2;DUSP1;EXOC2;RAC1;PRKCB;ADIPOR1;GSK3A;HIF1A;RND1;CEACAM1;CCNK;RPTOR;DUSP16;MAPRE3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5869234838313638,1.2170436831652498,0.2622641509433962,0.7733703972282653,1.0,6/10,22.26%,ATXN3;CYLD;TNFAIP3;OTUD4;DESI2;STAMBP
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3602552054647207,1.214946365786731,0.11316397228637413,0.7739876026203016,1.0,31/254,8.56%,LEF1;MECOM;ETS1;ERG;ELK3;ZIC3;SOX17;KLF7;MEF2C;FOXO1;ZBTB16;PRDM2;IRF2;HHEX;FOXF1;RREB1;CREB1;KLF4;NKX2-8;NR1H2;GTF2I;IRF5;SOX18;NFIC;SOX12;HINFP;JUN;ATF6B;TCF12;KLF6;ELK4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.4757723773167168,1.21476458839929,0.21035598705501618,0.7682364393983718,1.0,4/33,3.78%,RNF144B;DCUN1D3;FOXL2;RNF125
prerank,CoA-ligase activity (GO:0016405),-0.5004347709767158,-1.214115614698808,0.22272727272727272,0.692793075762194,1.0,4/14,15.55%,ACSL1;ACSS3;AACS;ACSS1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5778855910721991,1.2132214018243797,0.25,0.7670799738326266,1.0,1/11,1.89%,DDAH1
prerank,protein phosphatase 1 binding (GO:0008157),0.5165939458327694,1.212762443534586,0.2545454545454545,0.7623767371694052,1.0,5/21,9.53%,PPP1R16B;PPP1R9B;KCNQ1;PHACTR4;PPP1R11
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5023979486566504,-1.2126473320208766,0.24,0.6888103339041166,1.0,2/14,2.84%,SLC26A7;SLC26A2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4136724142488707,-1.2120746944857477,0.1736842105263158,0.682116770652143,1.0,13/33,25.66%,AR;CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4;TBP;WAC;UVSSA;SMYD2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4679021892230445,1.2082953315499976,0.23252032520325203,0.7702725949940042,1.0,6/34,5.11%,ARAP3;MYO10;ARAP2;HIP1R;PARD3;CYTH3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4019364970097073,1.2078161272593015,0.17606602475928473,0.7657382938134834,1.0,18/91,10.68%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;SNX3;KCNQ1;SYT7;PIRT;PLEKHA5;FCHO2;TWF2;CAPG;AMER2;CLVS2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4072739734105964,1.2025867487401234,0.19943019943019943,0.7753900872871631,1.0,8/71,5.14%,PTPRG;PTPRM;PTPRB;PTPRJ;DUSP23;PTPN12;DUSP3;CDC14A
prerank,water transmembrane transporter activity (GO:0005372),0.5869225520676519,1.2011554439451304,0.2644320297951583,0.7734379073118249,1.0,2/11,4.59%,AQP11;AQP7
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.44772789975567573,-1.201048730485374,0.23863636363636365,0.7064586582261634,1.0,4/21,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5520800025669561,1.200646149594487,0.2851919561243144,0.7691013550450939,1.0,5/12,8.10%,PDE2A;PDE8A;PDE4D;PDE7B;PDE4B
prerank,nuclear export signal receptor activity (GO:0005049),-0.5358167949439155,-1.2003875880949586,0.25103734439834025,0.7000688196892282,1.0,4/11,16.48%,RANBP17;XPO5;XPO6;XPO1
prerank,CXCR chemokine receptor binding (GO:0045236),0.573538867624241,1.2002189702633441,0.29320388349514565,0.7643136598645707,1.0,1/11,1.41%,CXCL12
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4541914009840863,1.200018018095634,0.22168284789644013,0.7591771961493811,1.0,4/35,5.89%,GPCPD1;PLCB4;PLD4;GDPD1
prerank,kinase binding (GO:0019900),0.34009151989872916,1.197608908594703,0.0832420591456736,0.7604822988519615,1.0,82/434,12.68%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;CAV1;FAS;PDE8A;BCAR3;TRIM14;TBC1D14;PTPRJ;RGCC;STX1A;PTK2;SP100;IFNAR2;ACVRL1;NOD2;TIAM1;PIK3IP1;MAP3K1;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;CALM1;GRB2;CTNNB1;CEP68;HSP90AB1;CD4;RHOB;TTC28;TSKS;ATP1A4;ADAM10;RFFL;PPP2R5A;CDKN2B;IRF5;PTPRR;CD160;LRBA;IRGM;FAM83G;ACSL3;IQGAP1;RPS7;PTN;CAV2;ARHGEF7;SHC3;CDK5RAP2;MSN;PPP1CB;CCND3;CNOT9;BTG1;GRB7;DCX;PDCD10;SMAD1;NBEAL2;PRKAB1;TOLLIP;CDC6;HSPB1;FERMT2;EXOC2;UBQLN1;RAC1;ADIPOR1;HIF1A;RND1;CEACAM1;CCNK;RPTOR;MAPRE3;WWC1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.26711256998005234,-1.1964288127654679,0.0,0.7036839649436901,1.0,129/731,13.14%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;MXI1;TOP1;IKZF2;HOXB4;PRRX2;CREB3L2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;SIX1;TBX18;EBF4;IKZF4;BCL6;TEAD3;CHD2;HEYL;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;HSF2;ATOH8;CREB3L1;STAT5A;ZNF23;FOXO3;SOX6;MGA;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1;GATA6;ZNF697;ZNF182;ZBTB38;NR2F1;ZNF148;PRMT5;ETV1;TFCP2L1;RXRA;ESR1;PGR;ZNF219;HOXB5;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.43996387957495403,-1.1920342443725689,0.2534562211981567,0.7087383617629073,1.0,4/23,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,aminopeptidase activity (GO:0004177),-0.42330280468989023,-1.1918176226818895,0.21323529411764705,0.701322036044715,1.0,5/26,8.24%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4575836964891319,-1.1918156484568534,0.2191142191142191,0.6933863016281631,1.0,6/20,15.29%,MOGAT3;AGPAT4;LPGAT1;LCLAT1;GPAT3;PNPLA3
prerank,cytokine receptor binding (GO:0005126),0.3984938173373837,1.1898852877542883,0.18811881188118812,0.7774290765375523,1.0,16/83,13.42%,KITLG;TGFB2;CXCL12;IL6R;PXDN;SOCS2;OSMR;PGF;LIFR;ADAM17;CNTF;TNFSF11;SYK;IL27RA;DDT;SDCBP
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.37645911214862054,-1.1898491096637105,0.18133333333333335,0.6916506211295562,1.0,6/46,4.19%,B3GALT1;LARGE1;EXT1;MGAT3;MGAT4C;OGT
prerank,amino acid binding (GO:0016597),0.4674204432999673,1.1889793064497824,0.2677165354330709,0.7744018182063845,1.0,10/31,20.55%,NOS3;DDAH1;NOS2;GRIN3B;SHMT2;GRIN2B;GRM7;GLRA2;AGXT;ASS1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.2645817916615519,-1.1886082677349026,0.0,0.687538503093877,1.0,112/732,11.02%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;MXI1;TOP1;IKZF2;HOXB4;PRRX2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;SIX1;TBX18;EBF4;IKZF4;BCL6;TEAD3;CHD2;HEYL;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;HSF2;ATOH8;STAT5A;ZNF23;FOXO3;SOX6;MGA;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1;GATA6;ZNF697;ZNF182;ZBTB38;NR2F1;ZNF148
prerank,alpha-tubulin binding (GO:0043014),0.46618017349296315,1.1859053495287994,0.24019607843137256,0.7779543377167876,1.0,5/31,8.53%,TTLL7;EFHC2;DIP2B;FYN;TRIM36
prerank,hormone receptor binding (GO:0051427),0.5415402663759078,1.1848248253806004,0.2926829268292683,0.7754701362977758,1.0,2/14,4.86%,SOCS2;NPPA
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4919665239756833,1.1789866911123832,0.2823920265780731,0.7876834975718399,1.0,6/24,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,TBP-class protein binding (GO:0017025),0.4887000283805067,1.1759473027758627,0.2869415807560137,0.7913537910811594,1.0,6/21,19.85%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,acid-thiol ligase activity (GO:0016878),-0.5008585170626372,-1.175466452995361,0.2639821029082774,0.7177296806068746,1.0,4/13,15.55%,ACSL1;ACSS3;AACS;ACSS1
prerank,calcium-release channel activity (GO:0015278),-0.46670409011908587,-1.1749193420883455,0.28117359413202936,0.7115895780559758,1.0,5/17,13.36%,ITPR1;PKD2;RASA3;ITPR2;TPCN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.5320572383634254,-1.172457693229505,0.297008547008547,0.7113762598314637,1.0,1/10,0.41%,DPYSL3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.574741357897146,1.1698008672888243,0.2942271880819367,0.7987093314483155,1.0,5/10,20.82%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.574741357897146,1.1698008672888243,0.2942271880819367,0.7987093314483155,1.0,5/10,20.82%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,SUMO transferase activity (GO:0019789),-0.4602743266236884,-1.168307660623494,0.24361948955916474,0.7158130804726458,1.0,5/16,18.80%,HDAC4;PIAS1;PIAS2;NSMCE2;MUL1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5743767329648977,1.164216563389599,0.301498127340824,0.8098341711551117,1.0,4/10,12.15%,PIK3R3;PIK3C3;PIK3C2A;PIK3CB
prerank,cholesterol transfer activity (GO:0120020),0.5257365541259539,1.1641865423045554,0.2926829268292683,0.804201874262729,1.0,2/16,4.02%,PLTP;ABCG1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.44909471935397016,1.159394878116443,0.27495908346972175,0.812884206135923,1.0,10/35,12.18%,FES;PTK2;ZAP70;LYN;FYN;YES1;HCK;PTK6;SYK;TNK2
prerank,lysophospholipase activity (GO:0004622),0.49366801000572613,1.1565326769448339,0.2970639032815199,0.8158078986435711,1.0,5/20,8.87%,PLA2G4B;PNPLA6;GDPD1;ENPP2;LYPLA1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2534825613870671,-1.154287790991243,0.0,0.7484993232898249,1.0,116/831,10.10%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;AEBP1;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;OSR1;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;CUX1;MXI1;TOP1;IKZF2;HOXB4;PRRX2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;PURG;SIX1;TBX18;EBF4;ZNF25;IKZF4;BCL6;TEAD3;NFXL1;CHD2;HEYL;HOXC8;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;ATF5;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;RBAK;HSF2;ATOH8;STAT5A;ZNF23;FOXO3;SOX6;MGA;TWIST2;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5445636597482977,1.1511408677439612,0.32326820603907636,0.8267920412811838,1.0,4/12,5.69%,PIEZO1;TMEM63B;TMC5;TMC7
prerank,protein phosphatase inhibitor activity (GO:0004864),0.46372350134813706,1.1502326295567131,0.309328968903437,0.8239370198163868,1.0,13/26,26.11%,PPP1R9B;PPP1R2;PTN;PPP1R11;PPP1R14C;PPP1R8;BOD1;PPME1;SET;ENSA;PABIR1;LMTK2;PPP1R14A
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4973782308056277,-1.1501339798924801,0.2955032119914347,0.7533357602982612,1.0,6/12,6.60%,IGF1;IRS1;SHC1;ARRB1;IGF2;GNAS
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.522730557496078,-1.14945849930316,0.29774127310061604,0.7474111075455782,1.0,5/10,16.92%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,O-acyltransferase activity (GO:0008374),0.4531096168860204,1.14901984331466,0.2835314091680815,0.8223512110508534,1.0,16/30,25.84%,MBOAT1;AWAT2;LPCAT3;PRDX6;LRAT;MOGAT2;DGAT1;MBOAT7;LPCAT2;MBOAT2;LPCAT4;DGAT2;GPAT4;GPAM;PLAAT1;LPCAT1
prerank,protein phosphatase regulator activity (GO:0019888),0.4062327000757962,1.1489989135254035,0.262699564586357,0.8168558867274902,1.0,14/53,16.89%,PPP1R16B;PPP1R9B;CALM1;PPP4R1;PPP1R2;PPP2R5A;PTN;PHACTR4;PPP1R15B;B3GAT3;PPP2R2C;BOD1;PPME1;SHOC2
prerank,I-SMAD binding (GO:0070411),-0.479313546416241,-1.1486153775446162,0.2995689655172414,0.7420630916941948,1.0,6/13,9.16%,SMAD3;SMAD6;TGFBR1;SMAD9;TGFB1I1;AXIN1
prerank,hyaluronic acid binding (GO:0005540),0.5674495309666214,1.1463238964794833,0.3205828779599271,0.8197761985590066,1.0,2/10,5.07%,LAYN;HYAL2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5248857239914543,1.137824386230214,0.3339382940108893,0.8408042833602704,1.0,3/13,9.68%,SH3BP4;CCDC88A;ARHGDIA
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5223469037414591,1.1372422254377943,0.3125,0.8371657938060085,1.0,1/14,0.03%,SPOCK2
prerank,phospholipase C activity (GO:0004629),0.4627513911429155,1.1367253130441266,0.31074380165289256,0.8331653259754344,1.0,6/25,11.57%,PLCB1;PLCB4;PLCG1;PLCH2;CHRM3;PLCH1
prerank,anion channel activity (GO:0005253),0.38712043235171084,1.1354832461019293,0.2796486090775988,0.8315682554056315,1.0,21/61,19.47%,LRRC8B;LRRC8C;CLCA2;GABRB1;CLCN3;CLIC4;GPR89A;GPR89B;TTYH3;GABRQ;LRRC8D;CLCN7;GABRG1;CLCC1;CLIC1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,BMP binding (GO:0036122),0.5499921121587233,1.1350000432901102,0.3211009174311927,0.8276299906210753,1.0,2/11,1.29%,ENG;BMPR2
prerank,guanyl ribonucleotide binding (GO:0032561),0.3410510715160388,1.1314215790520976,0.24094881398252185,0.8325718279233532,1.0,31/196,11.99%,MFHAS1;INSR;RHOBTB1;PDE2A;RAPGEF2;GCH1;RAB31;GBP7;GBP4;GBP5;CNGA2;TGM2;ARF5;REM2;RHOB;RALB;DNM2;RAP1B;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;RAB3B;EIF2B2;RAC1;HRAS;MMAA;RAB4A;TUBD1;RND1
prerank,GTPase activity (GO:0003924),0.3410227733691425,1.1312409301515967,0.23934837092731828,0.8278209630852211,1.0,31/192,13.02%,DNM3;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MTG1;GNA12;RHOB;EFTUD2;TBC1D24;RALB;DNM2;RAB11A;RAP1B;IRGM;GTPBP1;GPN3;GFM1;RAB3B;RAC1;HRAS;MMAA;RAB4A;RND1;GNB1;GPN2;RAB1A
prerank,microtubule motor activity (GO:0003777),0.4088295283371295,1.128775593335447,0.2997076023391813,0.8297482270091262,1.0,9/51,12.40%,STARD9;KIFC3;DNAH3;KIF26A;KIF2A;KIF1A;KIF3B;KIF23;DNAH8
prerank,GABA receptor binding (GO:0050811),-0.5003324783557462,-1.1271899985546125,0.3399122807017544,0.7993687215992867,1.0,6/11,26.58%,TRAK1;PLCL2;ARFGEF2;SHISA7;AKAP5;LHFPL4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.47359082892989285,1.1268310473874779,0.34574468085106386,0.8304046328848745,1.0,12/19,25.86%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GABRA2;GRID1;GABRG2
prerank,ligand-gated channel activity (GO:0022834),0.4434436267258564,1.1256792932308444,0.29516129032258065,0.8284681046699559,1.0,9/29,13.66%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,copper ion binding (GO:0005507),-0.36228332652072115,-1.125624597625357,0.26944444444444443,0.7961984343520699,1.0,7/42,7.23%,MOXD1;LOXL3;PAM;SOD3;LACC1;ATP7A;P2RX4
prerank,tubulin binding (GO:0015631),0.3259343904518247,1.1254342512120454,0.21296296296296297,0.8240249399252086,1.0,54/295,12.61%,DNM3;TTLL7;MTUS1;EFHC2;REEP1;STARD9;ARHGEF2;MAP4;FGF13;DIP2B;CCDC69;STMN1;KIF26A;CLIP1;TTLL5;MAPRE2;RP1;CCDC88A;FYN;CCDC88B;KIF2A;KIF1A;STMN3;DNM2;RAB11A;STMN4;MAP6D1;BRCA2;MARK4;EML5;MAP1LC3B;ARHGEF7;TRIM36;CDK5RAP2;AGBL5;EML6;PAK1;RITA1;DCX;HAUS6;KIF3B;CCT5;CRIPT;HOOK1;PEX14;S100A8;KIF23;MAP10;MID1;POLB;MAP4K4;TERF1;MAPRE3;EML1
prerank,microtubule binding (GO:0008017),0.33499329482163287,1.1249702043761518,0.23564593301435408,0.8204108539612417,1.0,40/222,12.61%,DNM3;MACF1;MTUS1;REEP1;STARD9;ARHGEF2;MAP4;FGF13;CCDC69;KIF26A;CLIP1;MAPRE2;RP1;CCDC88A;CCDC88B;KIF2A;KIF1A;DNM2;RAB11A;MAP6D1;MARK4;EML5;MAP1LC3B;CDK5RAP2;EML6;DCX;HAUS6;KIF3B;CRIPT;HOOK1;PEX14;S100A8;KIF23;MAP10;MID1;POLB;MAP4K4;TERF1;MAPRE3;EML1
prerank,cholesterol binding (GO:0015485),0.4163996720570451,1.1240131029445541,0.29430379746835444,0.8181190965659518,1.0,6/47,8.94%,PROM1;CAV1;OSBPL1A;ABCG1;OSBPL10;NPC1
prerank,ligand-gated ion channel activity (GO:0015276),0.439397554929442,1.1217171939352846,0.3072,0.8196897311237825,1.0,9/30,13.66%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,nucleotidyltransferase activity (GO:0016779),0.4725647648296899,1.1192330417210608,0.3274021352313167,0.8217129780392203,1.0,2/19,5.11%,TENT4A;MTPAP
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3365091280886973,-1.1179505298675725,0.24846625766871167,0.8117807892689235,1.0,12/53,11.94%,MICAL3;DDO;MICAL2;AOX1;DPYD;POR;NOX4;PRODH;MTHFR;CRY2;KDM1A;AIFM2
prerank,channel activity (GO:0015267),0.41334018360478597,1.1139797318124836,0.3313161875945537,0.832316453218215,1.0,4/41,7.08%,AQP11;MCUB;AQP7;CHRNB1
prerank,glucuronosyltransferase activity (GO:0015020),0.4768641129536917,1.1130840574012326,0.3368055555555556,0.8299839863370786,1.0,1/19,0.34%,CSGALNACT1
prerank,galactosyltransferase activity (GO:0008378),0.5398668672695628,1.1117903780132532,0.360377358490566,0.8286662041129815,1.0,2/11,2.42%,B4GALT5;B4GALT4
prerank,vitamin D receptor binding (GO:0042809),-0.4625187303268752,-1.110980362381793,0.35648148148148145,0.8248002270499988,1.0,6/14,25.19%,MED14;RXRA;MED30;MED4;MED24;MED16
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4831811743539538,-1.1098205973825388,0.36075949367088606,0.8203480026003911,1.0,2/11,3.35%,EGFR;MAP3K5
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5085054033731891,1.1094496810336405,0.356140350877193,0.829959846318674,1.0,2/14,2.77%,MAL;NOD1
prerank,lipase activity (GO:0016298),0.40887255755699115,1.1092467851002799,0.3082942097026604,0.8256433982597935,1.0,5/43,12.55%,ABHD2;LIPE;LYPLA1;LIPC;PNPLA8
prerank,small GTPase binding (GO:0031267),0.339001970003019,1.1089360380830753,0.2775,0.8216496193381304,1.0,31/169,13.05%,DOCK4;FGD5;SRGAP2;SH3BP4;CAV1;UNC13B;ARHGEF2;RIN3;PEX5L;EPS8;USP6NL;PKN1;OCRL;RAPGEF4;NCKAP1;UNC13D;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;BICDL1;CYFIP1;KIF3B;EXOC4;EXOC2;TBC1D30;CYRIB;RANBP9;TMEM127;FGD2
prerank,ubiquitin-specific protease binding (GO:1990381),-0.4170791755184825,-1.1081301477899612,0.308584686774942,0.8174987304629978,1.0,6/19,13.58%,AMFR;LCOR;PRKN;SELENOS;SYVN1;PTEN
prerank,lipid phosphatase activity (GO:0042577),0.5111759201405259,1.107026189233226,0.3442028985507246,0.822362243598224,1.0,2/14,3.82%,SGPP2;PLPP6
prerank,sterol binding (GO:0032934),0.3922376071865662,1.1067157968426702,0.3078078078078078,0.8184106129761548,1.0,5/56,4.02%,PROM1;CAV1;OSBPL1A;OSBP;ABCG1
prerank,ATP hydrolysis activity (GO:0140603),0.4119648725976576,1.106015634052496,0.3104575163398693,0.815666285879981,1.0,6/41,10.97%,MYO1E;KIF26A;ABCA3;ATP2B1;DNA2;ABCD1
prerank,microtubule minus-end binding (GO:0051011),0.5080070628244343,1.104696831951585,0.3693379790940767,0.8148764844639063,1.0,1/13,1.09%,MACF1
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.33427356542326664,-1.1046243026658558,0.288961038961039,0.8198740217355518,1.0,13/60,11.28%,CTDSPL;PPM1E;LRRK1;CDC14B;PHLPP2;PPM1D;MTMR3;PPM1B;CTDSPL2;PPEF2;PPP1R3C;LRRK2;PPP3CB
prerank,protein kinase inhibitor activity (GO:0004860),-0.35280007478789155,-1.104029608965537,0.2934472934472934,0.8139557669182287,1.0,10/42,18.22%,PARVA;GMFB;SPRED1;QARS1;IBTK;DUS2;DNAJC3;CDKN1C;MAPK8IP1;SMCR8
prerank,GTP binding (GO:0005525),0.33668214192130874,1.1028381827595561,0.2806573957016435,0.8155253979764495,1.0,27/172,11.99%,MFHAS1;INSR;RHOBTB1;GCH1;RAB31;GBP7;GBP4;GBP5;TGM2;ARF5;REM2;RHOB;RALB;DNM2;RAP1B;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;EIF2B2;RAC1;HRAS;MMAA;RAB4A;TUBD1;RND1
prerank,translation elongation factor activity (GO:0003746),0.49867631904739385,1.102692211048751,0.3719298245614035,0.8113027859967245,1.0,7/14,22.56%,GTPBP1;EIF5AL1;EIF5A;GFM1;EEFSEC;GTPBP2;EEF1B2
prerank,RNA stem-loop binding (GO:0035613),-0.4711522400028161,-1.1003565006821867,0.3197424892703863,0.817525575647033,1.0,4/12,14.89%,EPRS1;FMR1;DDX3X;LARP6
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.43572641132373935,-1.0991476676483045,0.36179775280898874,0.8135306211625973,1.0,5/17,13.10%,DPYD;BDH2;PTGR2;PECR;DECR1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3750628818629945,-1.0980404942010003,0.31070496083550914,0.8091263918626739,1.0,14/32,20.24%,KDM7A;KDM2A;EGLN3;KDM2B;P4HTM;PHF8;TMLHE;PHYH;ALKBH1;BBOX1;RIOX2;JMJD4;HSPBAP1;TYW5
prerank,chloride transmembrane transporter activity (GO:0015108),0.48664450044359575,1.0973194511199198,0.37005163511187605,0.8224326563724613,1.0,1/16,0.40%,SLC1A1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5285314561304675,1.0900034119605806,0.4098360655737705,0.8375808659173474,1.0,2/11,12.88%,CNGA2;HCN2
prerank,G protein-coupled receptor activity (GO:0004930),0.3211702743509489,1.0888905002966789,0.28125,0.8360002481552983,1.0,38/239,17.02%,ADGRL4;ADGRE5;ADGRL2;ADGRL3;HCRTR1;S1PR1;ADGRG1;LPAR6;APLNR;CALCRL;CCR7;XPR1;OXTR;ADRA2B;GPR17;OPN5;HCRTR2;CXCR2;GPR52;GPR22;NPR1;AGTR2;CYSLTR1;ADCYAP1R1;TPRA1;MTNR1A;GPR171;GPR75;GPR85;OPN3;RXFP3;RXFP2;GPR62;OPRD1;GRM8;SSTR1;GLP1R;S1PR4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.47236167592169476,1.0865625088749575,0.3541284403669725,0.8331245670997456,1.0,5/16,19.47%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.47236167592169476,1.0865625088749575,0.3541284403669725,0.8331245670997456,1.0,5/16,19.47%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,receptor tyrosine kinase binding (GO:0030971),0.3838436213204329,1.0860378435911784,0.34750733137829914,0.8299603063925036,1.0,8/56,10.44%,GRB14;DOCK4;DUSP3;ELMO2;HYAL2;SHC3;SOCS5;ACP4
prerank,gated channel activity (GO:0022836),0.5039484012656867,1.0850820304840818,0.3960923623445826,0.8281264370236366,1.0,4/14,5.69%,PIEZO1;TMEM63B;TMC5;TMC7
prerank,translation initiation factor activity (GO:0003743),0.4158882631198109,1.0822640104259253,0.3462157809983897,0.8312709767199751,1.0,14/36,16.71%,EIF3F;EIF3E;EIF2B1;EIF3D;MTIF3;EIF2B2;EIF4E;EIF3B;EIF3G;EIF3L;EIF3M;EIF1B;COPS5;EIF4A1
prerank,methyl-CpG binding (GO:0008327),-0.3980712758258409,-1.0794529824561816,0.36855036855036855,0.8574933277824449,1.0,15/22,35.88%,CXXC5;ZBTB38;PRMT5;CXXC4;ZBTB4;MBD2;ERH;TET1;ZCWPW1;UHRF1;MBD3;MBD1;LRWD1;PRMT1;LHX4
prerank,transcription coregulator binding (GO:0001221),-0.33920535024223725,-1.0767708183579625,0.3430232558139535,0.8577079157023102,1.0,15/50,12.24%,SMAD3;THRB;PER3;CCNT2;USP11;NEK6;EHMT2;RORA;AR;PER2;LCOR;MED25;VGLL4;ESR1;PGR
prerank,sequence-specific DNA binding (GO:0043565),-0.2420898216262407,-1.0750999712937357,0.1568627450980392,0.8551627975947093,1.0,122/590,17.97%,FOXP2;PBX1;MAF;ZIC1;ZEB2;NR2F2;ZIC4;GLI3;RARB;ZBTB20;GLI2;CREB5;FOXD1;HLF;SMAD3;PKNOX2;HOXC4;ARNT2;OSR1;TEAD1;NR6A1;HOXA5;NFAT5;MEOX2;THRB;HDAC4;CUX1;HOXB4;PRRX2;TEF;NR1D2;HOXB6;FOXC2;FOXC1;TBX15;PPARGC1A;RBPJ;ZNF423;HOXA7;RORA;GLIS2;PPARA;PBX4;RUNX2;KLF3;SIX1;TBX18;BCL6;HOXC8;NR3C2;KDM2A;SIRT3;FOXJ2;NFATC4;ATF5;ELF4;ZSCAN29;BCL2;KLF15;VSX1;RFX7;FBXL19;KDM5B;FOXL1;KDM2B;POU6F1;HSF2;CREB3L1;ZNF23;FOXO3;CXXC5;ARNT;CEBPB;ELK1;GATA6;ZBTB38;NR2F1;ZNF148;PRMT5;CXXC4;ETV1;KDM1A;TFCP2L1;RXRA;ABL1;ESR1;XRCC5;HOXB5;FOXE1;SNAI1;SP3;ZBTB4;MAFB;MTF1;GZF1;HOXA9;ATF2;NR4A1;ZBTB7B;E2F3;RFX5;SREBF1;NFIB;MYBL2;FOXJ3;ZBTB26;SMG1;NR1H4;NFATC2;JDP2;HOXB2;HOXA6;MBD2;RARA;SIX4;HOXA2;HIC1;ZNF177;PAX2;CALCOCO1;FOXD2;BATF
prerank,ionotropic glutamate receptor activity (GO:0004970),0.46482238674040044,1.072876199125802,0.3824561403508772,0.8535216272451268,1.0,9/17,24.02%,GRIN3B;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIA2;GRIK3;GRIN1
prerank,calcium channel inhibitor activity (GO:0019855),0.5199339554099607,1.0702401888514312,0.41154562383612664,0.8561878984441328,1.0,3/11,4.35%,MCUB;SLC30A1;CALM1
prerank,kinase activity (GO:0016301),0.34301347972416807,1.06763246646202,0.36253369272237196,0.8589546118220174,1.0,22/109,13.91%,ITPKB;DGKH;PRKD1;LYN;PRKD3;DGKI;EPHA4;DGKE;PKN2;CHKA;CERKL;PGM2L1;PDXK;PIK3C3;PIK3C2A;IPMK;DGKZ;PIK3CB;MAP4K4;PANK3;CERK;PSTK
prerank,cytokine receptor activity (GO:0004896),0.35517159808367293,1.0664525336254627,0.3557422969187675,0.8577635467910748,1.0,17/83,12.97%,IL1R1;IL6R;IFNAR1;FZD4;IFNAR2;IL10RB;OSMR;CD4;IL17RD;IL13RA2;IL4R;GPR17;LIFR;EBI3;IL20RB;IL27RA;IL7R
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.46815738096482684,-1.065911005859556,0.40816326530612246,0.875533430364233,1.0,7/12,23.81%,KDM7A;KDM3B;KDM1A;PHF8;PHF2;KDM4D;HR
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4550197030684432,1.061478114031177,0.39759036144578314,0.8671966373815303,1.0,4/20,10.08%,TJP2;MAGI3;AK4;CMPK1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.49577734567251125,1.0607749031868239,0.40298507462686567,0.8644516636470244,1.0,4/12,3.18%,ENG;LTBP4;BMPR2;ACVRL1
prerank,neuropeptide receptor binding (GO:0071855),0.476527132601259,1.060746833092121,0.3978102189781022,0.8599888675804125,1.0,3/14,18.55%,NPPA;PPY;NTS
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.4586862111178259,1.0604053829707716,0.40250447227191416,0.8565459601776412,1.0,4/18,3.18%,ENG;LTBP4;BMPR2;ACVRL1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4685818992604128,1.0589849009573669,0.40394973070017953,0.8557470488261057,1.0,1/16,0.40%,SLC1A1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.41139148135505493,1.0589574417518794,0.3865814696485623,0.8514499280969038,1.0,11/33,20.62%,CNOT6L;NOCT;PDE12;PAN2;DCP2;CNOT6;DIS3L;EXOSC10;XRN1;EXOSC9;XRN2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.45269357170511965,1.0577751656399796,0.3818493150684932,0.8503916330730305,1.0,1/21,0.28%,POLK
prerank,1-phosphatidylinositol binding (GO:0005545),0.4787614208359221,1.0568503989977038,0.41100917431192663,0.8485546502865106,1.0,3/15,7.28%,SCARB1;EPB41;WDFY3
prerank,DNA polymerase activity (GO:0034061),0.44466986299059663,1.055005849546286,0.3925549915397631,0.8494956951060978,1.0,1/22,0.28%,POLK
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.26295141453595056,-1.0543808219268578,0.3036649214659686,0.9025374968649088,1.0,36/188,11.75%,BNC2;PBX1;SOX5;ZBTB20;SMAD3;SMAD6;HDAC4;GABPB2;PER3;CREB3L2;FOXC2;FOXC1;BCOR;TBL1XR1;AR;PER2;GLIS2;SIX1;TBX18;GLI1;ZNF568;ATF5;KLF15;CHD3;VSX1;YAP1;CREB3L1;FOXO3;SOX6;CEBPB;ELK1;GATA6;RNF10;CRY2;MTERF3;RXRA
prerank,iron ion binding (GO:0005506),-0.3292740495350573,-1.0526378713483293,0.37026239067055394,0.9001436098466642,1.0,18/48,28.86%,AGMO;AOX1;KDM7A;EGLN3;FXN;PHF8;PHYH;ALKBH1;FDX1;PHF2;TYW5;DNAJC24;FTL;TET1;ACO2;FBXL5;ACP5;SCD
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4747907928409966,1.0508089227255317,0.41114982578397213,0.8563190235331173,1.0,2/15,5.02%,SLC1A1;SLC1A2
prerank,palmitoyltransferase activity (GO:0016409),0.42661394424310806,1.0503010474137826,0.417910447761194,0.8534599990716045,1.0,6/28,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,GTPase inhibitor activity (GO:0005095),-0.44543783172183227,-1.0465834366871416,0.4272930648769575,0.9100257454926161,1.0,2/13,2.27%,CPEB2;SLIT2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4572369230762415,-1.0457694136147904,0.4044943820224719,0.9048434361601119,1.0,2/11,7.09%,ITPR1;RASA3
prerank,syntaxin-1 binding (GO:0017075),0.43282602790750135,1.0439773674098285,0.4075993091537133,0.866681264722471,1.0,6/22,14.09%,UNC13B;SYPL1;STXBP1;SYNPR;CPLX1;SYPL2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5113309079419183,1.0418044979879462,0.4392523364485981,0.8684382171856714,1.0,4/11,17.21%,KCNQ1;KCNH2;KCNJ3;KCNJ5
prerank,histone deacetylase binding (GO:0042826),0.34406044252645274,1.0416906648065605,0.4031339031339031,0.864457370959977,1.0,9/88,8.41%,LEF1;MEF2C;HDAC9;HSP90AB1;TAL1;PKN1;PKN2;INSM1;FOXP3
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.35814356434970146,-1.0412368896418993,0.38005390835579517,0.9109689101941756,1.0,13/33,25.66%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;SPTY2D1;ELP4;WAC;UVSSA;ERBB2;SMYD2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.42981856681833935,-1.040480526986833,0.40707964601769914,0.9054487689078442,1.0,8/14,34.93%,ALDH4A1;MTHFR;MTHFD1;AASS;PYCR3;PYCR1;ALDH1L1;CRYM
prerank,cAMP response element binding (GO:0035497),-0.47155799622988626,-1.040344828751273,0.4096638655462185,0.8982589972716392,1.0,5/10,14.31%,CREB5;CREB3L2;CREB3L1;E4F1;ATF2
prerank,tropomyosin binding (GO:0005523),-0.4135130963839846,-1.0390035520233825,0.3978260869565217,0.8946904145735891,1.0,6/16,17.24%,CALD1;S100A6;LMOD1;TMOD3;TNNT3;TMOD2
prerank,carboxy-lyase activity (GO:0016831),0.42841348326118556,1.038256542404472,0.4172661870503597,0.8697965445586602,1.0,1/23,0.61%,DDC
prerank,protein kinase regulator activity (GO:0019887),-0.2896008967379198,-1.0378683384644873,0.3667953667953668,0.8907654485951934,1.0,23/95,16.02%,PRKAG2;PARVA;CCNT2;GPRC5C;GMFB;CCNL1;CCND2;QARS1;ELP3;STK11;CCNC;PRKAG3;CCNH;ANKRD54;STRADA;WNK1;DUS2;WNT11;CCNE2;ELP4;GPRC5A;DNAJC3;CDKN1C
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.44425917062138787,-1.0344923099550922,0.41721854304635764,0.8934481443719375,1.0,7/12,37.59%,AIFM2;NQO1;DCXR;CRYZ;DHRS4;CRYZL1;CBR1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4282719922915886,1.0321493308265117,0.41264559068219636,0.8823140018755918,1.0,3/24,10.08%,ITPKB;AK4;CMPK1
prerank,nuclear receptor binding (GO:0016922),0.3285556026525983,1.0315937229020362,0.41542625169147496,0.8794853734486242,1.0,18/111,12.54%,LEF1;NCOA1;CTNNB1;PKN1;ACTN4;STAT1;BUD31;NCOA2;TACC1;YWHAH;ARID1A;HMGA1;SRARP;OASL;PRKCB;ZBTB7A;HIF1A;GTF2B
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.46905905404699555,-1.0308252470832342,0.44123711340206184,0.8975522632061225,1.0,5/10,13.30%,CACNA1C;CACNA1D;CACNB4;CACNB2;CACNB1
prerank,phosphatase inhibitor activity (GO:0019212),0.43456951793115794,1.0306483364858443,0.4196277495769882,0.8776548649456661,1.0,8/20,24.85%,PPP1R9B;PPP1R2;PTN;BOD1;PPME1;SET;ENSA;LMTK2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.40115187250594725,1.0305646489014433,0.4444444444444444,0.8736868166591943,1.0,19/35,30.31%,TAF1B;STAT1;RRN3;GTF2B;POU2F1;ZBTB17;NR3C1;UBTF;TAF4;TBPL1;FOXP1;TAF1C;MYC;SMARCA4;AGO1;SNAPC3;PARK7;TP53;DR1
prerank,actinin binding (GO:0042805),0.4339974088043004,1.0258786487188063,0.42160278745644597,0.882229984275371,1.0,2/21,2.01%,PROM1;MAGI1
prerank,voltage-gated anion channel activity (GO:0008308),-0.42095806310370565,-1.025088883067234,0.42857142857142855,0.9070691457331261,1.0,4/15,9.40%,ANO6;CLCN2;ANO1;CLCN6
prerank,heme binding (GO:0020037),0.3541293426772699,1.0238072277264643,0.402002861230329,0.8834125996515398,1.0,11/65,10.85%,NOS3;FLVCR2;CYP2E1;PXDN;NOS2;CYP11B1;CYP11A1;CAT;TBXAS1;CBS;CYBB
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3571494240459057,-1.0222458351668264,0.4228855721393035,0.9081407603372024,1.0,7/27,21.73%,LRP1;APOE;HSP90B1;APBB3;AP2A1;SNX17;LANCL1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.38168537627609456,-1.0216233288040186,0.44730679156908665,0.9027639865736713,1.0,3/22,4.91%,SCN7A;PKD2;CACNA1G
prerank,potassium ion antiporter activity (GO:0022821),-0.40866772241992283,-1.0191567872595435,0.42990654205607476,0.9022784972456194,1.0,5/15,11.17%,SLC24A3;SLC9A2;SLC9A9;SLC9A1;SLC24A5
prerank,WW domain binding (GO:0050699),0.41417114426063667,1.0163105190608677,0.47058823529411764,0.8993018978601028,1.0,6/26,18.20%,RAPGEF2;NDFIP2;TNK2;TCEAL6;TCEAL5;DAZAP2
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.24818952500148242,-1.0144740369980898,0.3841059602649007,0.9093633035209358,1.0,51/232,16.51%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;PIAS1;DTX4;DTX3;RNF145;DTX1;RNF217;SH3RF2;TRAF3IP2;MGRN1;PRKN;UBR5;SMURF2;RNF135;LRSAM1;CUL3;KCMF1;TRIM63;RNF10;HUWE1;NHLRC3;WWP2;MYLIP;RNF181;NFX1;PPIL2;PIAS2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;RNF121;TRIM9;NSMCE1;TRIP12;RNF144A;DTX2;UBR2;UBR3;MKRN1;RCHY1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.39240505140986875,1.013774525726165,0.4697452229299363,0.9016924449670166,1.0,10/34,20.62%,CNOT6L;NOCT;PAN3;PDE12;PAN2;CNOT6;DIS3L;EXOSC10;EXOSC9;XRN2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4339591518404381,-1.0125962856884867,0.46444444444444444,0.9076511907056166,1.0,4/13,15.29%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.40605992893662235,1.009880354130932,0.43936731107205623,0.9080085502898283,1.0,5/26,13.25%,CSGALNACT1;B3GNT2;B3GALT4;B4GALNT1;B3GALT2
prerank,ion channel activity (GO:0005216),-0.2880946468381191,-1.0075749134767873,0.4233576642335766,0.9160641586161854,1.0,10/80,8.56%,TRPM3;NALCN;PIEZO2;PKD2;ABCC9;TRPM6;ANXA6;CALHM2;CALHM5;TRPC6
prerank,titin binding (GO:0031432),-0.421748128779988,-1.0074110817812976,0.46588235294117647,0.909597957074781,1.0,3/13,10.39%,ACTN2;CAMK2D;TRIM63
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.37182290770912735,1.0061645601960434,0.45858895705521474,0.9133926347641603,1.0,2/44,3.46%,MECOM;MEN1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.23758742637439256,-1.005811814945209,0.43564356435643564,0.9075346659900217,1.0,77/346,17.69%,RNF220;PDZRN3;RNF152;PELI2;UBE2E2;RNF43;SH3RF3;CBLB;AMFR;BCOR;ASB2;TTC3;DTX4;DTX3;TRIM23;FBXO10;RNF145;FBXW8;DTX1;RNF217;UBE2R2;SH3RF2;TRAF3IP2;MGRN1;PRKN;PJA2;UBR5;UBE2E1;RNF214;SMURF2;RNF135;PML;UBE2M;LRSAM1;DDB2;CUL3;RNF31;KCMF1;BTRC;TRIM63;RNF10;KLHL13;HUWE1;NHLRC3;AKTIP;WWP2;MYLIP;RNF20;RNF181;NFX1;UBE2E3;PPIL2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;FBXW11;RNF121;TRIM9;KLHL42;NSMCE1;TRIP12;RNF144A;UBE2B;DTX2;UBR2;UBR3;MKRN1;RCHY1;FBXO4;TRAIP;UBR4;FBXO9;UBE2Q1;MEX3C
prerank,anion:anion antiporter activity (GO:0015301),-0.3952415874405547,-1.0048235414280728,0.45901639344262296,0.9035468579799921,1.0,3/17,8.95%,SLC26A7;SLC26A2;SLC4A2
prerank,N-acetyltransferase activity (GO:0008080),-0.39307639895187163,-1.0002259588780513,0.47368421052631576,0.910263278972623,1.0,12/19,37.84%,SAT1;NAA80;EP300;SAT2;NAT2;NAT8L;NAA50;AANAT;SMARCE1;ESCO1;NAT10;NAT1
prerank,metal ion binding (GO:0046872),0.2808488212829522,0.9998775759005084,0.48272138228941686,0.9262811913512499,1.0,79/477,14.18%,SPOCK2;CSGALNACT1;RASGRP3;ESYT2;LTBP4;PDE2A;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;STK38;SPARCL1;AGRN;SNRK;HPRT1;SNN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;NT5C3A;CDH8;MTPAP;CAMKK2;PIR;SYT7;PRKACB;ESYT1;RASGRP2;RET;IDH3A;DCHS1;CDH19;SRI;CRNN;CETN2;MAP3K6;IQGAP1;PDXK;ENPP2;NRXN1;SPOCK1;LETM1;DNER;HPGDS;CLGN;NUDT3;LRP2;S100A8;TPM4;PPP3CA;SYT4;CDH10;CDH23;PPP3R1;DXO;CALB2;EML1;CPNE6;MAN1B1;CERK;STK3;CDH5;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;FAN1;HACL1;XYLT2;MOV10L1;PDCD6
prerank,carboxylic acid binding (GO:0031406),0.37667566417097514,0.9990831751722054,0.47433903576982894,0.924061958628334,1.0,8/38,14.46%,NOS3;NOS2;SESN3;GRIN3B;SHMT2;GRIN2B;MAG;GRM7
prerank,ATPase regulator activity (GO:0060590),-0.3353721057587082,-0.9990096998281446,0.43523316062176165,0.9072773307281473,1.0,12/38,21.13%,FNIP1;SIL1;ATP1B3;ATP1B2;BAG1;TOR1AIP1;BAG3;ATP5IF1;DNAJB4;DNAJB2;TSC1;DNAJC24
prerank,myosin binding (GO:0017022),-0.3064913510361187,-0.998820776212591,0.44785276073619634,0.9011474808746404,1.0,5/55,3.47%,CALD1;KIRREL1;GSN;TRAK1;DMD
prerank,RNA polymerase II complex binding (GO:0000993),-0.34520729769480113,-0.9978563119662245,0.47411444141689374,0.8976020258588226,1.0,8/32,15.33%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4
prerank,methylation-dependent protein binding (GO:0140034),-0.2999412532020575,-0.9971888163719436,0.4583333333333333,0.8929151936158506,1.0,12/57,15.31%,ZMYND8;KDM7A;PYGO1;SGF29;CHD8;CBX5;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2
prerank,calcium ion binding (GO:0005509),0.28759978129015,0.9943937117825112,0.4943181818181818,0.9322369168260147,1.0,47/323,12.62%,SPOCK2;RASGRP3;ESYT2;LTBP4;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;SPARCL1;AGRN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;CDH8;CAMKK2;SYT7;ESYT1;RASGRP2;RET;DCHS1;CDH19;SRI;CRNN;CETN2;IQGAP1;ENPP2;NRXN1;SPOCK1;LETM1;DNER;HPGDS;CLGN;LRP2;S100A8;TPM4;PPP3CA;SYT4;CDH10;CDH23;PPP3R1;CALB2;EML1;CPNE6
prerank,triglyceride lipase activity (GO:0004806),0.4138776515160876,0.9939346083493836,0.49312714776632305,0.9290892384463201,1.0,2/20,10.76%,LIPE;LIPC
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4539197553472224,0.9939016360162233,0.5132275132275133,0.9248964989059937,1.0,5/15,12.15%,PIK3R3;PIKFYVE;PIK3C3;PIK3C2A;PIK3CB
prerank,cation:chloride symporter activity (GO:0015377),-0.4448100935189192,-0.9933540341669301,0.474025974025974,0.8970290444577318,1.0,4/10,12.60%,SLC12A2;SLC6A1;SLC12A7;SLC12A4
prerank,ubiquitin protein ligase activity (GO:0061630),-0.2425384958433193,-0.9927749868643112,0.44047619047619047,0.8922860576158819,1.0,50/228,16.51%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;DTX4;DTX3;RNF145;DTX1;RNF217;SH3RF2;TRAF3IP2;MGRN1;PRKN;UBR5;SMURF2;RNF135;LRSAM1;CUL3;UBE4B;KCMF1;TRIM63;RNF10;HUWE1;NHLRC3;WWP2;MYLIP;RNF181;NFX1;PPIL2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;RNF121;TRIM9;NSMCE1;TRIP12;RNF144A;DTX2;UBR2;UBR3;MKRN1;RCHY1
prerank,histone methyltransferase binding (GO:1990226),0.47492173082511985,0.9916098220469277,0.5,0.9268167380218821,1.0,3/11,9.30%,CTNNB1;HSP90AB1;LCORL
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3598572350324857,0.9911926897643244,0.48148148148148145,0.9235447940135907,1.0,9/49,12.62%,ESYT2;DYSF;PLA2G4B;SYT7;CPNE8;ESYT1;CPNE5;SYT4;CPNE6
prerank,signal sequence binding (GO:0005048),0.3827134903211382,0.9889653128156495,0.46677740863787376,0.9252673606211975,1.0,10/35,19.37%,NFKBIA;PEX5L;CAT;AP2M1;RANBP6;AP2B1;TOMM20L;NUP153;KCNIP2;IPO4
prerank,ion channel inhibitor activity (GO:0008200),0.3814579228041847,0.988064483465322,0.46742671009771986,0.9235662314193218,1.0,5/35,4.35%,NEDD4L;STX1A;MCUB;SLC30A1;CALM1
prerank,chemokine binding (GO:0019956),-0.3462640203596802,-0.9872561159945834,0.47354497354497355,0.9017280962319679,1.0,4/30,10.36%,PDPN;CCR9;FGF2;ITGAV
prerank,protein kinase C binding (GO:0005080),0.3645012749614811,0.9851281297257409,0.4831804281345566,0.9269944819034501,1.0,14/43,14.97%,TIRAP;PRKD2;HDAC9;HDAC7;HINT1;PKN1;CCDC88A;ADCY4;TWF2;CAVIN2;HSPB1;PRKCB;NELL2;HDAC5
prerank,endopeptidase activator activity (GO:0061133),0.4786967108428812,0.984732956210896,0.4847908745247148,0.9239640864806159,1.0,7/10,27.29%,PSME2;APH1A;VSIR;NLRC4;APH1B;PSME1;ADRM1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3453954811078752,-0.9831508180348784,0.4883116883116883,0.9071376052820226,1.0,6/27,6.46%,SLC26A7;SLC26A2;SLC39A14;SLC22A6;SLC5A5;ANO1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4471031815840547,0.9802543952212621,0.4748201438848921,0.9314775475898199,1.0,5/13,13.39%,KCNQ1;PRKAR2B;PRKAR2A;GSK3A;SOX9
prerank,endopeptidase inhibitor activity (GO:0004866),0.3307066697631947,0.9791646190105711,0.4888888888888889,0.9299657811404812,1.0,10/82,9.50%,SPOCK2;APP;SERPINB5;SERPINA9;SERPINA11;BST2;CST7;PZP;SPOCK1;SERPINI1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.3256853746970077,-0.9751421120502344,0.48404255319148937,0.9230996725223585,1.0,8/34,17.66%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UFC1;UBE2B;UBE2Q1
prerank,transition metal ion binding (GO:0046914),-0.2270154750858469,-0.9745271183143742,0.5294117647058824,0.9185130677024679,1.0,62/397,11.96%,MPPED2;AGMO;GLI2;TIMP2;MOXD1;SMAD3;LARGE1;PAPPA;ENPP1;AOX1;SEC24D;ZFPM2;HDAC4;MMP16;ACER3;CBLB;SEC24A;ANPEP;LOXL3;PAM;ME1;ADCY2;ZMYND8;BAZ1B;KDM7A;MDM4;ENPP3;IKZF4;SOD3;TDP2;UPB1;LACC1;ZEB1;KDM2A;ATP7A;SIRT3;P2RX4;SOD2;CHD3;PRKN;ACE;ENPEP;FBXL19;KDM5B;NPEPPS;EEA1;KDM2B;RBAK;CHD4;CXXC5;PTGR2;ADAM33;SEC23A;B4GALT1;IDE;CRIP1;FAM20C;EPRS1;CXXC4;RXRA;PHF8;ABL1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32770476323414355,-0.9729181290805782,0.48641304347826086,0.916681195655683,1.0,6/38,6.75%,SERPING1;TFPI;ANXA2;SERPINH1;SERPIND1;SERPINF1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4680365453531088,0.9706260264560628,0.497164461247637,0.9479348050109524,1.0,5/10,24.77%,CDKN2B;KAT2B;INCA1;CDKN1B;CDKN2C
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.4665698846750532,0.9703853105416969,0.4936708860759494,0.9444514707358289,1.0,4/12,18.97%,STAT1;GTF2B;POU2F1;TBPL1
prerank,pyridoxal phosphate binding (GO:0030170),-0.36747264009728403,-0.9695556997102647,0.5,0.9195732845486294,1.0,10/20,27.79%,PYGB;PYGM;ABAT;OAT;ACCS;THNSL2;PYGL;PNPO;GLDC;SHMT1
prerank,carbohydrate kinase activity (GO:0019200),-0.42497744732433085,-0.9694373375583852,0.5181451612903226,0.9136952451697122,1.0,4/11,16.56%,HK2;GALK1;NAGK;GALK2
prerank,NAD binding (GO:0051287),-0.3487075690338563,-0.9687772193886736,0.4925373134328358,0.9095013745084991,1.0,5/26,8.29%,ALDH1A1;CRYL1;ME1;SIRT3;BDH2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.4322705873685223,-0.968185483643094,0.5203426124197003,0.9050656813839555,1.0,2/11,18.07%,SLC22A4;SLC25A29
prerank,ephrin receptor binding (GO:0046875),0.41107253936199073,0.9678846271889546,0.5180102915951973,0.9467816504682102,1.0,6/21,7.63%,ANKS1A;LYN;GRB2;FYN;ANKS1B;EFNA1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3796858729411233,-0.9677268035110573,0.5202020202020202,0.9003140984969915,1.0,4/19,10.59%,ITPR1;RASA3;P2RX4;TRPM4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.46371299330042215,0.9663953646321625,0.519774011299435,0.9465795646589393,1.0,4/11,13.64%,PPP1R2;PPP1R11;PPP1R14C;PPP1R8
prerank,nuclear localization sequence binding (GO:0008139),0.4231692111868079,0.9639017259560746,0.4876760563380282,0.9489108056697529,1.0,4/18,19.37%,NFKBIA;RANBP6;NUP153;IPO4
prerank,transferrin receptor binding (GO:1990459),-0.435442029859769,-0.9624771119704417,0.4892241379310345,0.9088274876190798,1.0,4/10,15.56%,RGMA;CHUK;CD81;IKBKG
prerank,transcription cis-regulatory region binding (GO:0000976),0.2748530347366694,0.9624533187229399,0.5719026548672567,0.948627656909079,1.0,42/406,9.18%,LEF1;ETS1;FLI1;DACH1;EPAS1;ELK3;ZBTB46;SOX17;MEF2C;SMARCA2;SOX13;MEN1;PRDM2;IRF2;HHEX;FOXF1;RREB1;SOX7;TCF23;BARHL1;KLF1;TAL1;ETV6;TCF7;SNAI2;ACTN4;KLF4;MAX;SOX18;PHOX2A;SOX12;HINFP;JUN;KCNH2;ZFP69;ATF6B;TCF12;PRDM9;CDK5RAP2;ZBTB14;SIM1;HMGA1
prerank,calcium channel regulator activity (GO:0005246),0.3657124201044526,0.9612668798528394,0.5132192846034215,0.9477647576317731,1.0,7/37,8.93%,MCUB;SLC30A1;PRKG1;CALM1;REM2;SRI;NRXN1
prerank,chloride channel activity (GO:0005254),0.32665831178818655,0.9604351339067371,0.5278195488721804,0.9458099638252917,1.0,18/59,19.47%,TTYH2;CLCA2;GABRB1;CLCN3;CLIC4;TTYH3;GABRQ;CLCN7;GABRG1;CLCC1;CLIC1;GABRG3;PACC1;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3705609340486024,-0.9596727546910917,0.515625,0.9107947580837364,1.0,5/18,11.44%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;AKR1B10
prerank,methylated histone binding (GO:0035064),-0.28485496758830897,-0.9592137537957871,0.5294117647058824,0.9060534244698601,1.0,14/62,18.75%,ZMYND8;KDM7A;PYGO1;SGF29;CHD8;CBX5;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2;CHD5;PHF2
prerank,MAP kinase kinase activity (GO:0004708),-0.3855519759738042,-0.9587723580202662,0.508695652173913,0.9012964330345334,1.0,8/15,22.58%,MAPKAPK3;LRRK2;MAPK14;MAP2K5;MAP2K3;MAP2K1;MAP2K4;MAP3K9
prerank,metal ion:proton antiporter activity (GO:0051139),0.4438019782680568,0.9581920143347996,0.5236486486486487,0.947489091039087,1.0,5/13,9.42%,SLC9A5;SLC9A3;LETM1;SLC9A7;SLC9A6
prerank,ribosome binding (GO:0043022),-0.2982107042001539,-0.9580562912024458,0.5240793201133145,0.897357504479121,1.0,15/46,22.70%,CPEB1;CPEB2;MRPS27;EIF3C;FMR1;SRP72;NCLN;IGHMBP2;EIF2A;YTHDF1;SEC61B;C1QBP;SEC61A2;SRP68;CPEB4
prerank,Notch binding (GO:0005112),0.3957135062352715,0.954867034273455,0.5134680134680135,0.9516915372647669,1.0,7/22,10.24%,NOTCH4;JAG2;DLL4;DNER;KCTD10;ADAM17;DLK2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3290266034326712,-0.9537111467216436,0.5442359249329759,0.90281819184384,1.0,4/29,3.53%,SLC13A3;SLC26A7;SLC26A2;SLC1A5
prerank,Hsp70 protein binding (GO:0030544),0.37023387162429877,0.9534040582341784,0.5108514190317195,0.9510634556463463,1.0,4/31,7.85%,NOD2;CYP2E1;FICD;SACS
prerank,ligand-gated cation channel activity (GO:0099094),0.32499003196332077,0.9531392425028926,0.5452054794520548,0.9477091125093412,1.0,18/75,19.84%,MCOLN1;KCNK6;CHRNB1;GRIN3B;KCNH2;GRIA4;KCNN2;KCNN3;P2RX7;GRIN2B;GRIK5;GRIK2;GRIK1;TRPM8;KCNJ3;KCNJ5;KCNJ6;GRIA2
prerank,histone acetyltransferase activity (GO:0004402),-0.32365185635671156,-0.9508921395997548,0.5396419437340153,0.9042650058669215,1.0,14/30,27.92%,ARRB1;KAT6B;HAT1;ATF2;EP300;MCM3AP;BAZ1A;NAA40;TAF9;KAT14;NAA50;CREBBP;KAT8;EPC1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.4293625252245322,-0.9497380026497126,0.5414847161572053,0.9015864216813442,1.0,6/10,27.39%,NSD2;SETD5;SETD2;NSD1;SMYD2;SETMAR
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.39447255891700406,-0.9495892916706172,0.5436241610738255,0.89637950885788,1.0,4/15,15.29%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,NAD+ binding (GO:0070403),-0.4183320869596698,-0.94868230869861,0.5251509054325956,0.8930865995403802,1.0,5/12,23.40%,CRYL1;SIRT3;SIRT2;HADH;SIRT6
prerank,potassium:proton antiporter activity (GO:0015386),0.4645566693638773,0.94820984583742,0.5441696113074205,0.9558686843681677,1.0,4/10,9.42%,SLC9A5;SLC9A3;SLC9A7;SLC9A6
prerank,exopeptidase activity (GO:0008238),-0.29270776974004564,-0.9481231460365592,0.5565217391304348,0.8890134121691665,1.0,15/50,21.19%,ANPEP;FAP;NAALAD2;ACE;ENPEP;NPEPPS;DPP4;CTSH;CTSZ;ACE2;ZMPSTE24;CTSA;DPP7;XPNPEP3;GGH
prerank,gap junction channel activity (GO:0005243),0.3935210558584556,0.9449974713769348,0.5306451612903226,0.9596940411810524,1.0,2/22,1.84%,GJD3;GJC1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4070653613532681,-0.9446289416069104,0.543778801843318,0.8928812454508126,1.0,1/13,0.81%,PLPP3
prerank,dynactin binding (GO:0034452),-0.40431035751274785,-0.9439320964664001,0.5204081632653061,0.8892220817173715,1.0,5/12,23.65%,SNX6;BICD1;SNX5;BBS4;HTT
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.42096104328097694,0.943611395315624,0.5333333333333333,0.9591307340384603,1.0,1/15,3.45%,PLA2G4B
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4503025262577074,0.9432983688406392,0.5507745266781411,0.955947973293721,1.0,5/12,9.42%,SLC9A5;SLC9A3;LETM1;SLC9A7;SLC9A6
prerank,wide pore channel activity (GO:0022829),0.3901808006230113,0.942560062265612,0.5464743589743589,0.9537920743698035,1.0,2/23,1.84%,GJD3;GJC1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.370249870794475,0.9424936510414077,0.5557432432432432,0.950047811973809,1.0,6/32,10.88%,KCNQ1;KCNC2;KCNG2;KCNH2;KCNQ3;KCNA4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3764333206597672,0.9414780312173114,0.545144804088586,0.9484298432933725,1.0,12/28,25.86%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GABRA2;GRID1;GABRG2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.41510542720700316,-0.939533610704001,0.5691609977324263,0.895279334271848,1.0,4/11,5.61%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,SH2 domain binding (GO:0042169),-0.32379668400080314,-0.9381723452980749,0.5602094240837696,0.8932760250073022,1.0,4/31,3.78%,AFAP1;IRS1;SH3PXD2B;DAG1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.44408931519915645,0.9374575997872746,0.538878842676311,0.9544141374101537,1.0,4/12,17.56%,OPN5;GPR52;OPN3;RRH
prerank,N-methyltransferase activity (GO:0008170),-0.3660329212635936,-0.9374549062296678,0.5700712589073634,0.8898466328143784,1.0,6/20,25.40%,HNMT;NNMT;TRMT1L;FDXACB1;DIMT1;RNMT
prerank,aspartic-type peptidase activity (GO:0070001),-0.43174289546182043,-0.9372639362294665,0.5494505494505495,0.8850461612313627,1.0,2/10,12.41%,BACE2;PSEN1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.3892586487581039,-0.9368907166593081,0.5480093676814989,0.880672473662056,1.0,2/14,17.39%,DHRS3;RDH10
prerank,MAP kinase activity (GO:0004707),-0.3886985352361876,-0.9320230859340205,0.5424107142857143,0.8877869884432774,1.0,1/14,0.68%,MAPK4
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3716331077687211,0.9317153427644572,0.5475409836065573,0.9640478070017132,1.0,9/29,20.82%,GCH1;PTPRJ;DUSP7;DUSP1;DUSP16;DUSP8;TNIP1;ATF7;DUSP6
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3725844634290083,-0.9311886625825543,0.5764966740576497,0.8846208173187722,1.0,3/16,13.99%,SLC22A4;SLC5A7;SLC22A2
prerank,zinc ion binding (GO:0008270),0.27081029985796057,0.930802491284996,0.6477404403244496,0.9623808040764474,1.0,51/293,13.51%,SHANK3;MYRIP;PDE2A;SORD;GCH1;TNFSF10;KLF7;ARHGEF2;IFIH1;RNF125;BHMT2;PRDM2;SAMHD1;CRIP2;CLIP1;CD4;RPS29;ZDHHC20;KLF4;MSRB2;MSRB3;KAT6A;SHMT2;TIMM13;PDXK;ENPP2;TRIM24;SNRPC;PGGT1B;KDM4A;HPF1;ZMYND11;TIMM10;ZNF205;DUSP12;S100A8;CTCF;GRIN2B;RPS27;GTF2B;PPARG;CYLD;LTA4H;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,steroid hydroxylase activity (GO:0008395),-0.37413807172526115,-0.9306940832789732,0.5591647331786543,0.8806317069034046,1.0,3/16,5.39%,CYP7B1;CYP27A1;CYP1B1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3803277468938012,0.9282761563312502,0.5352112676056338,0.964540593043257,1.0,5/25,4.51%,NOS3;CYP2E1;FMO2;FMO4;NOS2
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2698701405762676,-0.9274940223957293,0.5952380952380952,0.8831541047518495,1.0,6/70,4.19%,GXYLT2;B3GALT1;LARGE1;EXT1;MGAT4C;OGT
prerank,neurexin family protein binding (GO:0042043),-0.42523294173722986,-0.9245240555849482,0.5676274944567627,0.8852197211037415,1.0,2/10,6.07%,NLGN2;SYTL5
prerank,NF-kappaB binding (GO:0051059),0.3782758849931628,0.9232580478507459,0.5488215488215489,0.9727521032101504,1.0,6/24,20.35%,NFKBIA;FOXP3;BCL10;TAF4B;CPNE1;COMMD7
prerank,peptidase activator activity (GO:0016504),0.38730177761232426,0.9214204138220354,0.5531914893617021,0.9733321497480152,1.0,5/22,11.81%,CAV1;MAL;PSME2;APH1A;VSIR
prerank,receptor ligand activity (GO:0048018),0.27087485423421714,0.9194763289363049,0.6460071513706794,0.9740830342289201,1.0,27/245,12.66%,KITLG;SEMA3C;SEMA7A;SEMA6A;PDGFB;TGFB2;JAG2;SEMA6B;WNT7A;NPPA;FGF16;SEMA4F;SEMA6D;TGFB1;TGFA;PTN;GREM1;FAM3D;PGF;SEMA4C;METRN;CNTF;PPY;TNFSF11;GDF15;TNFSF12;IL15
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.31298825476867576,-0.9182136788736328,0.574025974025974,0.8955701148375462,1.0,7/31,17.66%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UBE2B;UBE2Q1
prerank,ubiquitin protein ligase binding (GO:0031625),0.27005478598834115,0.9177204369808207,0.660069848661234,0.9746095478111524,1.0,60/254,19.23%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;FOXO1;CD40;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;CBS;ACTG1;UBXN1;PRKAR2A;TRIB2;AXIN2;SMAD5;CASP8;UBOX5;HSPA8;HIF1A;MID1;TNK2;GGN;ARRDC1;UQCRC1;RPL11;BCL10;TPI1;RBX1;DNAJA1;PRDX6;ELOB;RNF8;APC;HERC2;SUMO1;YWHAZ;RALA;BAG6;MAP1LC3A;HSPA9;SLF1;HLTF;UBE2D1;RPL23;TRAF3;USP25
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2587658507142431,0.9168720619811274,0.7019867549668874,0.972564529762236,1.0,73/431,15.19%,MFHAS1;ABCC6;INSR;RHOBTB1;MAP4K2;MAP4K3;GCH1;RAB31;STK38;SNRK;ACVRL1;GBP7;GBP4;PRAG1;GBP5;ZAP70;ABCG1;TGM2;SARS2;ABCD4;ARF5;REM2;HSP90AB1;MTPAP;RHOB;PRKACB;RPS6KA5;ATP1A3;ATP1A1;RALB;DNM2;YARS2;RAP1B;FICD;ADSS2;PXK;MARK4;ARL4A;RAB39A;ARHGEF5;TWF2;MAP3K6;PDXK;TUBB;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;RAC1;HRAS;MMAA;RAB4A;TUBD1;ATP5F1A;RND1;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;RHOV;PFKL;TBCK;STK26;DYNC1LI1;TUBB4B;TUBA1A;ARL4D
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2671538260559311,0.9151802035920257,0.6643518518518519,0.9727500542036928,1.0,62/269,19.23%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;FOXO1;CD40;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;STAT1;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;CBS;ACTG1;UBXN1;PRKAR2A;TRIB2;AXIN2;SMAD5;CASP8;UBOX5;HSPA8;HIF1A;MID1;TNK2;HGS;GGN;ARRDC1;UQCRC1;RPL11;BCL10;TPI1;RBX1;DNAJA1;PRDX6;ELOB;RNF8;APC;HERC2;SUMO1;YWHAZ;RALA;BAG6;MAP1LC3A;HSPA9;SLF1;HLTF;UBE2D1;RPL23;TRAF3;USP25
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4327384829271399,0.9143101847592489,0.5766423357664233,0.9709284517529517,1.0,4/13,12.15%,PIKFYVE;PIK3C2A;PIP4K2A;PIK3CB
prerank,ATPase activator activity (GO:0001671),-0.3446150565334932,-0.9134334216571752,0.6097560975609756,0.9018724871472377,1.0,7/20,24.52%,ATP1B3;ATP1B2;TOR1AIP1;DNAJB4;DNAJB2;DNAJC24;AHSA1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.43292463465220576,0.912260503042056,0.5919117647058824,0.971623253974801,1.0,3/14,10.49%,MINDY1;ATXN3;MINDY2
prerank,protein heterodimerization activity (GO:0046982),0.27890028087940066,0.9105183277150543,0.6339622641509434,0.9720595225327633,1.0,21/178,11.82%,HIP1;EPAS1;PDGFB;BCL2L1;ZHX3;FZD4;MEF2C;RALGAPA1;ABCG1;IKBKB;ATP1A1;MCL1;SRI;YWHAH;IRAK2;SIM1;CYBB;TPM4;MTTP;UBA3;HIF1A
prerank,gamma-tubulin binding (GO:0043015),0.382196332884106,0.9090546766864371,0.5736842105263158,0.9716622003445362,1.0,8/21,17.65%,BRCA2;MARK4;ARHGEF7;CDK5RAP2;PAK1;GIT1;DIXDC1;NDRG1
prerank,serine-type peptidase activity (GO:0008236),-0.24746444800338432,-0.908610861135246,0.6962962962962963,0.9082606469767209,1.0,19/96,18.66%,PCSK5;HTRA3;F3;FAP;MMP2;NAALAD2;KLK2;DPP4;RHBDL3;HTRA1;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;PCSK6;GZMM
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.41553338278131924,0.9077915429884604,0.5858951175406871,0.9710167341699143,1.0,3/13,16.55%,DCT;DDT;IDI1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4021529933587816,0.9075552684875874,0.5896980461811723,0.9678160883221237,1.0,9/17,32.76%,AK4;CMPK1;NOL9;DTYMK;NME2;CMPK2;AK1;AK8;AK7
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4227583171577737,0.907423401036984,0.5772811918063314,0.9644442838036004,1.0,6/14,18.73%,KCNQ1;KCNH2;KCNJ3;KCNJ5;KCNA5;KCNIP2
prerank,3'-5' exonuclease activity (GO:0008408),0.33384158137052594,0.905828599011156,0.5954545454545455,0.9643608590232463,1.0,14/45,21.64%,CNOT6L;NOCT;MRE11;PDE12;PAN2;CNOT6;TRIR;DIS3L;REV3L;EXOSC10;EXOSC9;POLD1;XRN2;RAD1
prerank,mRNA binding (GO:0003729),-0.2183338879058142,-0.9039893520597791,0.8057553956834532,0.9141365518574414,1.0,49/249,17.24%,CELF2;RBMS3;SAMD4A;CPEB1;CPEB2;DDX5;SRRM2;RBMS1;HDLBP;RBPMS2;SRSF5;DCP1A;AUH;CSDC2;SNRNP70;AGO2;RBM47;YBX3;LUC7L3;ZC3H12B;PCF11;XPO5;FUBP1;FXR2;SRRM4;NOVA1;SRSF6;IGF2BP2;SRSF4;ACO1;RNF20;RBM5;LUC7L2;FMR1;HNRNPR;NSRP1;RBFOX1;DDX3X;PCBP4;LARP6;HNRNPA2B1;PABPC4;EIF2A;YTHDF1;TUT1;PABPC4L;FYTTD1;PCBP2;G3BP2
prerank,phosphatase binding (GO:0019902),-0.2434302091723912,-0.9033987198379352,0.7003891050583657,0.91038805121409,1.0,26/105,16.52%,EGFR;SMAD3;MAGI2;MAP3K5;IKBKE;ANAPC5;MAST2;DLG1;SH3RF2;DLG4;PDLIM4;AP3B1;MET;SPRED1;MTMR3;PPP1R3C;CRY2;RCAN3;TRPC4AP;HSP90B1;WNK1;PIK3R1;MAPK14;GTF2F1;MVP;NFATC2
prerank,DNA binding (GO:0003677),0.2500891058016383,0.9030285374423814,0.7662473794549266,0.9668090996845848,1.0,91/694,13.76%,LEF1;MECOM;ETS1;FLI1;ERG;EPAS1;KLF12;TRIM16;APP;ZIC3;TBX1;PPARD;TBX3;IMPDH1;LRRFIP1;RYBP;SMARCA2;ARID3B;FOXO1;FOXL2;SOX13;MEN1;YBX1;HMBOX1;KLF2;ZBTB16;PRDM2;IRF2;SAMHD1;HHEX;FOXF1;NTHL1;POGK;MRE11;SNAI2;ZCCHC3;AIM2;NKX2-8;STAT1;MAX;NR1H2;PALB2;IRF5;BRCA2;SOX12;HINFP;KAT6A;JUN;TSHZ2;FOXP3;PRDM9;ELK4;ZBTB14;ARID1A;SIM1;FANCG;DEDD2;HMGA1;ZMYND11;BANF1;MCM10;DNA2;LIN9;OASL;NR5A2;CBFB;TLR8;CTCF;RPS27;GTF2H4;ZBTB7A;HIF1A;MPG;JRK;SOX10;POLG2;TERF1;SLPI;PPARG;GTF3C5;WDR48;ZBTB33;POU2F1;CSRNP3;ORC1;TSNAX;SOX9;FAN1;RPS15;SNAPC1;HMGB2
prerank,SUMO binding (GO:0032183),-0.3828426873531421,-0.8998951531819869,0.6043956043956044,0.9137718411355532,1.0,6/13,21.97%,TDG;PML;HABP4;USPL1;UBA2;CASP8AP2
prerank,adenyl ribonucleotide binding (GO:0032559),0.25931272356777374,0.8964652033424438,0.7174418604651163,0.9781266144359606,1.0,50/291,14.58%,ABCC6;INSR;MAP4K2;PDE2A;RAPGEF2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;MYO6;ABCG1;SARS2;PDE4D;ABCD4;HSP90AB1;MTPAP;PRKACB;RAPGEF4;RPS6KA5;ATP1A3;ATP1A1;YARS2;FICD;PXK;MARK4;PDE4B;TWF2;MAP3K6;PDXK;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;ATP5F1A;HMGCR;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;PFKL;TBCK;STK26
prerank,serine-type endopeptidase activity (GO:0004252),-0.24663626842456718,-0.8961180484410929,0.6885245901639344,0.91765560008926,1.0,16/80,18.66%,PCSK5;F3;FAP;MMP2;KLK2;DPP4;RHBDL3;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;PCSK6;GZMM
prerank,semaphorin receptor activity (GO:0017154),-0.397514061053912,-0.8958698277226096,0.6202247191011236,0.9133278960005745,1.0,2/11,6.78%,PLXNA2;PLXNB2
prerank,calcium activated cation channel activity (GO:0005227),-0.3488179400021055,-0.895804219121149,0.5921658986175116,0.9085268496810534,1.0,4/17,10.59%,ANO6;KCNMB2;ANO1;TRPM4
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27392813811756295,0.8957037462524242,0.6749072929542645,0.9760888592679925,1.0,19/173,8.69%,DACH1;ELK3;KLF12;PPARD;TBX3;BCL6B;LRRFIP1;SOX13;ZBTB16;PRDM2;HHEX;ETV6;SNAI2;MAX;INSM1;JUN;ZFP69;FOXP3;ZBTB14
prerank,mRNA methyltransferase activity (GO:0008174),0.4248036549214656,0.8947730047030763,0.5833333333333334,0.9744690413412586,1.0,6/12,23.95%,TRMT10C;CMTR2;TRMT61B;CMTR1;METTL3;PCIF1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.40361422378894307,-0.8947364908895333,0.6063157894736843,0.9059409240871822,1.0,1/10,0.35%,PRKAG2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3022734158958049,0.8912153635828965,0.6440922190201729,0.97885262648636,1.0,16/74,12.82%,DGKH;NT5C3A;DGKI;DGKE;CHKA;PKM;PGM2L1;PDXK;PIK3C3;PIK3C2A;HK1;IPMK;DGKZ;PIK3CB;PANK3;NOL9
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3996891590593353,-0.8911418615686642,0.6024590163934426,0.9042247505517514,1.0,3/11,13.66%,SIL1;BAG1;BAG3
prerank,adenyl nucleotide binding (GO:0030554),-0.3996891590593353,-0.8911418615686642,0.6024590163934426,0.9042247505517514,1.0,3/11,13.66%,SIL1;BAG1;BAG3
prerank,acetylation-dependent protein binding (GO:0140033),-0.33688189680923086,-0.8887876622100208,0.6218097447795824,0.8997049403276849,1.0,4/20,9.70%,ZMYND8;PSME4;MLLT3;BRD9
prerank,lysine-acetylated histone binding (GO:0070577),-0.33688189680923086,-0.8887876622100208,0.6218097447795824,0.8997049403276849,1.0,4/20,9.70%,ZMYND8;PSME4;MLLT3;BRD9
prerank,ion gated channel activity (GO:0022839),0.35819150990948967,0.8885554030613263,0.5841750841750841,0.981186546791771,1.0,3/24,4.96%,TTYH2;TMEM63B;CLCA2
prerank,histone acetyltransferase binding (GO:0035035),0.37985330780562526,0.8861469243293472,0.6203389830508474,0.9829598418298195,1.0,5/21,11.82%,EPAS1;STAT1;FOXP3;ZBTB7A;HIF1A
prerank,neuropeptide hormone activity (GO:0005184),0.3687509612623826,0.8838492621534003,0.6175496688741722,0.9843121969162786,1.0,3/22,11.07%,NPPA;CALCB;PPY
prerank,general transcription initiation factor binding (GO:0140296),0.3537879400726306,0.8837683964229736,0.5851239669421487,0.9809002729189616,1.0,6/25,19.85%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2987944179015672,0.8812982105703013,0.6324167872648335,0.9828502011243129,1.0,3/75,2.22%,ABCC4;SORD;IMPDH1
prerank,ribonuclease activity (GO:0004540),0.31536776021844504,0.8811007146134022,0.643491124260355,0.9796885469022047,1.0,18/56,22.45%,SAMHD1;PIWIL1;N4BP1;INTS11;RNASEK;RNASE1;CNOT6;RNASE12;TSNAX;PPP1R8;SND1;EXOG;ENDOG;EXOSC10;DICER1;EXOSC9;RNASE6;EXOSC8
prerank,protein phosphatase activator activity (GO:0072542),0.4070776940631804,0.8796492582542508,0.6123893805309735,0.9795314058556817,1.0,4/13,14.63%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,phospholipase activity (GO:0004620),0.29978081293302505,0.8775774837094954,0.6724890829694323,0.9805840774721817,1.0,9/67,12.55%,PLCB4;PLA2G4B;PNPLA6;PLD4;GDPD1;ENPP2;LYPLA1;LIPC;PNPLA8
prerank,Wnt-activated receptor activity (GO:0042813),0.39309990631883124,0.8766809434237085,0.5918367346938775,0.9789412145587221,1.0,4/15,8.59%,FZD6;FZD4;TSPAN12;LRP5
prerank,N-acyltransferase activity (GO:0016410),0.34187460038178635,0.8763903993418027,0.6197654941373534,0.9759945317644276,1.0,4/32,5.58%,CERS4;TGM2;TLCD3B;GLYAT
prerank,MAP-kinase scaffold activity (GO:0005078),0.42502214328999477,0.8755650632209454,0.6033519553072626,0.974340279811019,1.0,3/11,8.39%,SH3RF1;SPAG9;IQGAP1
prerank,miRNA binding (GO:0035198),-0.2992508931489043,-0.8749236716289691,0.6741293532338308,0.9256218700287303,1.0,9/30,23.03%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;SPOUT1;RBM10
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.4013743866749379,0.8729234423290266,0.6322241681260946,0.9767421689487978,1.0,2/14,5.02%,SLC1A1;SLC1A2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.30120279421431434,-0.8723129338833892,0.6838235294117647,0.925926686013913,1.0,12/28,22.58%,PRKAA2;PRKACA;MAPKAPK3;LRRK2;MAPK14;MAP2K5;RPS6KB1;MAP2K3;TTK;MAP2K1;MAP2K4;MAP3K9
prerank,double-stranded DNA binding (GO:0003690),0.2437065923634884,0.8699476053842785,0.8273305084745762,0.9797276980533469,1.0,70/531,12.94%,LEF1;FLI1;ERG;ELK3;KLF12;ZIC3;TBX1;PPARD;TBX3;BCL6B;MEF2C;FOXL2;BACH2;MEN1;YBX1;HMBOX1;KLF2;IRF2;GATA2;SOX7;CREB1;NTHL1;BARHL1;MRE11;TCF7;IRF9;SNAI2;ZCCHC3;KLF4;AIM2;NKX2-8;STAT1;MAX;POU3F4;IRF5;SOX18;PHOX2A;NFIC;SOX12;JUN;ATF6B;TERF2;TCF12;KLF6;FOXP3;ELK4;ZBTB14;KLF13;FOXQ1;ZMYND11;ZNF32;CEBPD;ATOH7;ELF2;PKNOX1;SMAD5;NR5A2;LHX5;GTF2H4;ZBTB7A;LHX9;ONECUT1;SOX10;POLG2;TFEB;LHX6;TERF1;ZNF250;PPARG;WDR48
prerank,ankyrin binding (GO:0030506),0.377207989913933,0.8696313184632343,0.6237288135593221,0.9769197907289302,1.0,1/19,0.80%,SPTBN1
prerank,voltage-gated ion channel activity (GO:0005244),-0.355649424883118,-0.8688701925763254,0.6381156316916489,0.9284366839258767,1.0,2/14,4.66%,ANO6;PKD2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2717027038273693,-0.8680987629893736,0.7170868347338936,0.9252345149725306,1.0,10/49,15.04%,ATP1A2;MPPED2;PXYLP1;PTPN22;LHPP;DUSP10;ACP6;ARMT1;PHOSPHO2;ACP2
prerank,transforming growth factor beta binding (GO:0050431),0.36791804394522293,0.8679094310098332,0.6397941680960549,0.9769615032132084,1.0,5/23,5.46%,ENG;LTBP4;ACVRL1;HYAL2;NRROS
prerank,telomerase RNA binding (GO:0070034),0.36616295266385757,0.8663239089328707,0.6402027027027027,0.9769569275244713,1.0,8/22,21.66%,HNRNPC;DCP2;SNRPB;NHP2;NAF1;EXOSC10;XRN1;PINX1
prerank,tau protein binding (GO:0048156),0.32022074492596136,0.8598459024697175,0.6353677621283255,0.9875891746552273,1.0,15/40,22.48%,ACTB;HSP90AB1;FYN;MARK4;PIN1;MARK3;GSK3A;BAG2;BIN1;DYRK1A;DCTN1;BRSK2;SNCA;PRKAA1;LGMN
prerank,growth factor activity (GO:0008083),0.2889319418381957,0.855220619565798,0.6998535871156661,0.9932881888689592,1.0,7/74,10.58%,PDGFB;JAG2;FGF16;TGFA;PTN;PGF;CNTF
prerank,CoA hydrolase activity (GO:0016289),-0.3490542338439123,-0.8540141189886342,0.662621359223301,0.949978080590011,1.0,3/16,12.03%,ACOT8;ACOT11;HIBCH
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.33912514305907315,0.8521624596069296,0.6600331674958541,0.9960136091083702,1.0,5/29,10.98%,ACER2;HYAL2;ACER1;PARG;MGAM
prerank,adrenergic receptor binding (GO:0031690),0.3756713645329991,0.8519177870311533,0.644927536231884,0.9930890291818928,1.0,2/16,4.54%,RAPGEF2;PDE4D
prerank,hexosaminidase activity (GO:0015929),-0.36890370243786064,-0.8514393327771017,0.6560364464692483,0.950514287470471,1.0,4/12,13.89%,CEMIP;CEMIP2;HEXA;NAGA
prerank,peptide hormone receptor binding (GO:0051428),-0.3687071308742468,-0.8494113395447386,0.654320987654321,0.949645358841496,1.0,7/11,49.79%,PTHLH;VIP;GNRH1;UCN2;GPHB5;PSMC5;GHRH
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.39712683856865866,0.8491107337193255,0.6323529411764706,0.9951947874976078,1.0,6/12,21.31%,CDK19;BRD4;CCNK;MAPK1;CDK6;CDK4
prerank,acetyltransferase activity (GO:0016407),-0.28849889018640795,-0.8487095393485272,0.7116402116402116,0.9464307144579152,1.0,13/31,26.41%,KAT6B;SAT1;ELP3;NAA80;SPHK1;PAFAH2;EP300;SAT2;NAT8L;DBT;NAA50;CREBBP;KAT8
prerank,retinoic acid receptor binding (GO:0042974),0.36561934209018626,0.8447264495425957,0.6432246998284734,1.0,1.0,4/17,12.84%,ACTN4;TACC1;HMGA1;PPARG
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3095633109701811,0.8422231075155683,0.7127496159754224,1.0,1.0,14/49,19.24%,MINDY1;RNF169;UBXN1;OTUD7A;SHARPIN;MINDY2;UBQLN1;EPS15;TNFAIP3;RAD23A;BAG6;TNIP1;BRCC3;OTUD7B
prerank,DNA secondary structure binding (GO:0000217),0.3332327325722861,0.8421082339748973,0.6612377850162866,0.9990442831282665,1.0,7/31,16.58%,MEF2C;MEN1;HMGA1;RECQL4;HMGB2;MSH2;HMGA2
prerank,single-stranded DNA binding (GO:0003697),-0.23626691875081693,-0.8394691974479626,0.8206896551724138,0.960166022486608,1.0,35/93,32.97%,SSBP2;TOP1;RBMS1;FBH1;TDP2;RAD51B;FUBP1;RBBP8;REXO4;SMC6;CRY2;NUCKS1;IGHMBP2;ERCC1;PCBP2;DMC1;CDC45;TDP1;MCM3;MCM4;MCM5;MCM9;HMGB1;NUP35;HMCES;RAD51AP1;SETMAR;DHX36;SPRTN;NEIL3;MEIOB;PCBP1;RAD52;POU4F1;MCM8
prerank,antiporter activity (GO:0015297),0.36264930580953725,0.8370216020382398,0.6792452830188679,1.0,1.0,4/20,12.39%,ATP1A3;CLCN3;SLC35E4;SLC35C1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.32955373484633016,-0.8363403823793019,0.7219730941704036,0.9613517134425894,1.0,4/18,10.25%,ANXA2;ANXA1;CNN3;TMOD3
prerank,transforming growth factor beta receptor binding (GO:0005160),0.36228776488563763,0.8359213305024645,0.6440071556350626,1.0,1.0,6/18,12.34%,ENG;TGFB2;SMAD7;TGFB1;FERMT2;TGFBR2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23327373883316513,0.8340296239175057,0.9012605042016807,1.0,1.0,77/597,13.39%,LEF1;ETS1;FLI1;ERG;ELK3;KLF12;ZIC3;TBX1;PPARD;SOX17;TBX3;BCL6B;MEF2C;SMARCA2;FOXL2;SOX13;BACH2;MEN1;YBX1;HMBOX1;KLF2;IRF2;HHEX;GATA2;SOX7;CREB1;BARHL1;KLF1;TAL1;TCF7;IRF9;SNAI2;KLF4;NKX2-8;MAX;POU3F4;IRF5;SOX18;PHOX2A;NFIC;SOX12;HINFP;JUN;KCNH2;ATF6B;TCF12;KLF6;FOXP3;PRDM9;ELK4;CDK5RAP2;ZBTB14;KLF13;FOXQ1;ZNF32;CEBPD;MCM10;ATOH7;ELF2;PKNOX1;SMAD5;CDC6;NR5A2;LHX5;CTCF;ZBTB7A;LHX9;ONECUT1;SOX10;TFEB;LHX6;SOX11;ZNF250;PPARG;ZBTB33;ORC1;SOX9
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.252177715920941,0.8335490440270904,0.8223039215686274,1.0,1.0,21/181,8.90%,LMO2;PPARD;NFKBIA;TBX3;NCOA1;ZFPM1;ACTB;CTNNB1;TCF23;CREB1;TAL1;ACTN4;KLF4;STAT1;GTF2I;BUD31;NCOA2;TACC1;JUN;FOXP3;ARID1A
prerank,leucine zipper domain binding (GO:0043522),-0.3794321603813168,-0.832885881050324,0.6941964285714286,0.9630940380610686,1.0,1/10,0.50%,PAWR
prerank,filamin binding (GO:0031005),0.3984482298526751,0.8320453448465915,0.6654867256637168,1.0,1.0,2/11,4.13%,NEBL;RFLNB
prerank,transaminase activity (GO:0008483),-0.3678368101915599,-0.8307785920942287,0.6923076923076923,0.9622583690795684,1.0,3/11,11.72%,ABAT;OAT;GOT1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.33092230295831704,0.8298484687010298,0.6983606557377049,1.0,1.0,4/28,11.45%,DAB2IP;STAT1;PIDD1;TNFSF11
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2762302192002582,-0.8291423132010112,0.7593582887700535,0.9609125611895027,1.0,15/34,28.74%,EHMT2;SMYD3;SETD7;SETD4;EEF2KMT;KMT5B;EZH2;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;TTLL12;ANTKMT;METTL21C
prerank,chloride channel regulator activity (GO:0017081),0.37932861989580036,0.8278835598084532,0.6765734265734266,1.0,1.0,6/14,23.38%,STX1A;SGK1;SGK3;WNK2;VAMP8;STX8
prerank,GABA-A receptor activity (GO:0004890),0.3529475757413772,0.8263762437994834,0.6834532374100719,1.0,1.0,8/18,25.86%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,hydro-lyase activity (GO:0016836),-0.26744500350412387,-0.8262771771333883,0.7848837209302325,0.9615207974671814,1.0,20/41,26.71%,GMDS;HACD4;AUH;ECHDC2;HACD1;ACO1;ECHDC1;PCBD2;ECHDC3;EHHADH;CYP2S1;ENO2;ECI1;ENO3;HADHA;ALAD;L3HYPDH;ECHS1;UROS;ACO2
prerank,sodium:proton antiporter activity (GO:0015385),0.40080383150483745,0.82622733654329,0.6847635726795096,1.0,1.0,4/11,9.42%,SLC9A5;SLC9A3;SLC9A7;SLC9A6
prerank,G protein-coupled receptor binding (GO:0001664),0.2589101967832662,0.8241172511753425,0.7929226736566186,1.0,1.0,18/132,11.07%,CXCL12;REEP1;S1PR1;GNAI2;GNAQ;WNT7A;ZNRF3;HOMER2;GNA12;NPPA;INSL3;HOMER1;ARHGEF12;RTP4;UTS2B;CALCB;HSPA8;PPY
prerank,retinoid X receptor binding (GO:0046965),0.38683410938478113,0.8230606937403575,0.6842105263157895,0.9996877007156416,1.0,3/11,12.84%,TACC1;HMGA1;PPARG
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3491300456705059,-0.8224748855156726,0.6919431279620853,0.9639270861398604,1.0,2/12,7.30%,CYFIP2;AGO2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3752676538838672,0.8208613307014123,0.6940559440559441,1.0,1.0,8/14,32.76%,AK4;CMPK1;DTYMK;NME2;CMPK2;AK1;AK8;AK7
prerank,bHLH transcription factor binding (GO:0043425),-0.31647436475017027,-0.816361243520224,0.711943793911007,0.9705423726812322,1.0,2/19,1.40%,FHL2;SMAD3
prerank,histone deacetylase activity (GO:0004407),-0.3109987216419465,-0.8147794887035803,0.7403189066059226,0.9687515378421127,1.0,3/19,6.86%,HDAC4;MIER3;SIRT3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.32560457683212396,-0.8144353901855281,0.7096774193548387,0.9646848115665582,1.0,2/15,13.00%,CCR9;CMKLR1
prerank,protein serine/threonine kinase activity (GO:0004674),0.23299941513443356,0.813945815692386,0.8934240362811792,1.0,1.0,71/334,18.24%,PRKCH;BMPR2;MAP4K2;MAP4K3;STK38;PKN3;KALRN;SNRK;RPS6KA1;ACVRL1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;MAP3K8;PRKD3;IKBKB;PIKFYVE;MAST4;PKN1;LIMK2;PAK5;MAPK3;RPS6KA5;PKN2;MARK4;MARK3;MAP3K6;IRAK2;PAK1;EIF2AK4;STK33;BRD4;STK32C;SLK;PRKCB;GSK3A;SYK;CCNK;PDIK1L;MAP4K4;TGFBR2;RIOK1;HIPK2;CSNK2B;STK24;STK3;MINK1;PIM2;VRK1;SGK1;CAMK2B;GRK6;NEK3;HIPK3;PLK2;SGK3;SGK2;MAPK1;CPNE3;ACVR1;SIK2;TTN;MAP3K11;PRKCG;PRKCE;TBK1;PAK2;WNK2;CDK11B
prerank,potassium channel regulator activity (GO:0015459),-0.2565733744492247,-0.8124008544253232,0.7994428969359332,0.9635964284255916,1.0,6/49,6.15%,WNK4;KCNIP3;KCNMB2;ABCC9;DLG1;FLNA
prerank,chemokine receptor activity (GO:0004950),0.33803896499245434,0.8085271837318851,0.7045075125208681,1.0,1.0,5/24,17.12%,CCR7;GPR17;CXCR2;GPR75;CCR2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.39505866567613984,0.8079345526284454,0.6520912547528517,1.0,1.0,3/10,13.40%,NAA60;NAA16;NAA11
prerank,signaling receptor complex adaptor activity (GO:0030159),0.30645851356814197,0.807352621617676,0.7282780410742496,1.0,1.0,5/38,9.08%,SHANK3;CARD10;SORBS1;SPAG9;DEDD2
prerank,exoribonuclease activity (GO:0004532),0.38412372593401034,0.8072346357397554,0.7015503875968992,1.0,1.0,7/12,32.98%,CNOT6;EXOSC10;EXOSC9;EXOSC8;ZC3H12A;CNOT7;EXOSC3
prerank,chemoattractant activity (GO:0042056),0.3215876942458745,0.804641412715725,0.7383015597920277,1.0,1.0,1/26,0.84%,PDGFB
prerank,solute:proton symporter activity (GO:0015295),0.36143192705427496,0.8039300730849104,0.6897746967071057,1.0,1.0,1/16,1.24%,SLC39A8
prerank,deubiquitinase activity (GO:0101005),0.2661508217882709,0.8009575910919918,0.8130311614730878,1.0,1.0,23/88,20.14%,USP53;MINDY1;ATXN3;EIF3F;OTUD7A;MYSM1;MINDY2;PAN2;USP18;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1
prerank,phosphatase activity (GO:0016791),0.2702637080756892,0.8008904466599059,0.7761627906976745,1.0,1.0,17/73,17.46%,PTPRJ;PTPMT1;DUSP23;DUSP3;PLPP6;NOCT;OCRL;PPP1CB;ACP4;DUSP12;DUSP16;ENOPH1;LPIN3;DUSP8;PLPPR4;PLPP2;MINPP1
prerank,kinase activator activity (GO:0019209),-0.2773962253950893,-0.7992238689454055,0.7864864864864864,0.9818478010990073,1.0,7/30,15.71%,PRKAG2;GPRC5C;STK11;STRADA;WNK1;WNT11;GPRC5A
prerank,ATP binding (GO:0005524),0.23155265592156254,0.7991095841132565,0.8900462962962963,1.0,1.0,43/266,14.58%,ABCC6;INSR;MAP4K2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;ABCG1;SARS2;ABCD4;HSP90AB1;MTPAP;PRKACB;RPS6KA5;ATP1A3;ATP1A1;YARS2;FICD;PXK;MARK4;TWF2;MAP3K6;PDXK;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;ATP5F1A;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;PFKL;TBCK;STK26
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3829832567414715,0.7988692827359876,0.6809338521400778,1.0,1.0,1/10,2.13%,CD200
prerank,metallocarboxypeptidase activity (GO:0004181),-0.28557986717568173,-0.7972596363912511,0.7660098522167488,0.9805927404181456,1.0,6/26,15.39%,AEBP1;CPXM1;CPXM2;AGBL1;PEPD;ACE2
prerank,voltage-gated potassium channel activity (GO:0005249),0.26945149473122726,0.7962624621325564,0.7946554149085795,1.0,1.0,20/80,19.44%,KCNH8;KCNQ1;KCNC2;KCNK6;KCNG2;KCNH2;KCNN2;KCNN3;KCNQ3;KCNV1;KCNA4;KCNH7;HCN2;KCNF1;KCNJ3;KCNJ5;KCNJ6;KCNA5;KCNIP2;KCNC1
prerank,sodium channel activity (GO:0005272),-0.2663310636680609,-0.7958566243109738,0.8067885117493473,0.9783240812624588,1.0,3/37,4.91%,SCN7A;PKD2;CACNA1G
prerank,DNA-binding transcription factor binding (GO:0140297),0.23660384818670166,0.7938641081002639,0.8871733966745843,1.0,1.0,38/189,17.74%,LMO2;PPARD;TBX3;MEF2C;ZFPM1;HDAC9;HDAC7;PTMA;HHEX;CTNNB1;TCF23;CREB1;TAL1;CRTC1;KLF4;STAT1;GTF2I;TLE4;JUN;TCF12;HSPB1;ZBTB7A;TLE1;EIF4E;PPARG;HIPK2;ZBTB17;BBS10;SP1;CTBP1;HDAC5;RBL1;HCFC1;MEF2D;YWHAZ;LYAR;SIN3A;USF1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.34252764841477257,0.793370111108069,0.7279151943462897,1.0,1.0,8/19,29.08%,AFAP1L2;GREM1;GAS6;PAK2;NRG3;EGF;GRM5;DGKQ
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.35791362544152594,-0.7869187018560807,0.7516483516483516,0.9893270944089936,1.0,7/10,29.25%,HAT1;ATF2;EP300;NAA40;NAA50;KAT8;MSL3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36361839918983835,-0.7859822979740494,0.7325842696629213,0.9861351164908098,1.0,1/10,6.61%,LACC1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.2566948576642832,-0.7790276756735575,0.8108882521489972,0.9927533576261492,1.0,8/40,13.80%,DNMT3A;PCMT1;HNMT;NNMT;THUMPD3;ARMT1;COMT;PRMT8
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.267856046727572,0.7774111103364268,0.8233576642335766,1.0,1.0,14/69,16.94%,CERS4;ZDHHC14;ZDHHC9;GLYAT;ZDHHC20;KAT6A;AWAT2;ZDHHC18;LPCAT3;GTF2B;NAA16;MOGAT2;ZDHHC21;DGAT1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.35526572311830734,0.7759918820173807,0.7436823104693141,1.0,1.0,7/12,25.86%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,death receptor binding (GO:0005123),0.352466648772195,0.7755785837266692,0.7333333333333333,1.0,1.0,2/15,8.31%,DAB2IP;PIDD1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.3401487619221415,-0.7735337103743528,0.7449664429530202,0.9970790093526034,1.0,2/11,11.44%,AKR1B1;AKR1B10
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3542711863400009,0.7710248039745315,0.7195767195767195,1.0,1.0,1/15,1.24%,SLC39A8
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.2864228692989512,-0.7707854927471085,0.7614457831325301,0.9919866791066043,1.0,9/21,25.48%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK10;CDK9
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.2864228692989512,-0.7707854927471085,0.7614457831325301,0.9919866791066043,1.0,9/21,25.48%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK10;CDK9
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3328347271735491,-0.769255222852419,0.75,0.9897890053694637,1.0,3/12,15.69%,BACE2;PSEN1;HM13
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.3423989026712717,0.7668637949341698,0.7416974169741697,1.0,1.0,3/16,10.50%,NTHL1;CD38;SMUG1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.342176761147851,-0.7665318171669794,0.7700892857142857,0.9893915645546214,1.0,6/11,23.23%,CASP12;CASP3;CASP6;CASP4;PYCARD;CASP9
prerank,RNA binding (GO:0003723),0.20888085185814653,0.7654738747264301,0.997979797979798,1.0,1.0,313/1321,22.07%,TFRC;SORBS2;RBM20;SPTBN1;SYNE1;MACF1;NANOS3;NOVA2;QKI;FASN;PRPF38B;AGFG1;TRIM25;FLNB;LRRFIP1;MAP4;IFIH1;YBX1;NPM3;MSI2;TMSB4X;ADAR;SAMHD1;SARS1;SARS2;GRB2;SELENOH;NANOS2;NOCT;MRPL12;PIWIL1;HSP90AB1;RPL38;SLC25A5;MTPAP;EFTUD2;EIF4H;TLR3;NOL4;MRPL13;RPL13;NANOS1;PPIA;ACTN4;GPATCH1;PIN4;ZCCHC3;MRPL10;EDC3;RPL36A;PTBP3;MAK16;RPL3;ABT1;PKN2;STXBP1;ZNFX1;RNPS1;ACTN1;N4BP1;YARS2;BST2;RPL27;NPM2;RPSA;TLR7;MRPL14;JUN;SRP14;SNU13;TIAL1;PKM;NOP16;TDRD7;TWF2;EIF3E;RPS7;CSTF2;DHX37;RPL9;PDAP1;MSN;SNRPF;RPL18;SLC3A2;HNRNPC;SNRPC;GTPBP1;CCT3;PDCD11;RBM19;SCG3;EIF2AK4;LRRC47;MAGOHB;DNA2;RPL13A;EIF3D;OASL;EIF5A;ZCRB1;GFM1;HSPA8;HELZ2;HSPB1;TASOR;TLR8;RPS11;LARP1B;WDR36;RPL8;DCP2;MPHOSPH10;RBPMS;NCBP2;RPS27;PWP2;RPL19;GPKOW;NOL10;TRMT10C;RBM45;R3HDM1;UTP3;MRPL54;ATP5F1A;NELFCD;DXO;RPS9;MRPL28;ZFP36L1;MRPL20;RPP38;ASCC3;EIF4E;SLPI;ADAD1;RO60;EDF1;SNRPB;DCP1B;ZC3H11A;DHX32;PUM3;KMT2C;CCDC137;RBM42;TSNAX;RPL11;LTA4H;FSCN1;EIF3B;EIF3G;PPP1R8;ZC3H7A;RPL22L1;RPS15;HMGB2;PSTK;SRBD1;RPL37;METAP2;FAM98A;RPS28;STIP1;MOV10L1;SERBP1;RFTN1;ESF1;EIF3L;G3BP1;DYNC1LI1;RPS10;ELAVL1;UTP11;LBR;COA6;PNO1;TNS1;YTHDC2;ZBED4;TUBB4B;RTRAF;DDX55;FBRSL1;RALYL;IREB2;RCC2;NOC4L;FRG1;SND1;TSN;UBTF;EIF1B;NOL7;MRPL40;RPS25;AQR;MCRS1;MRPL44;ZC3HAV1;RPL37A;CS;YLPM1;MRPS9;MRPL9;PRPF40A;ZC3H13;ISG20L2;CPNE3;FAU;UBAP2;RPP21;DDX18;NHP2;RBFOX3;UNC50;SUMO1;EIF4A1;ALKBH8;YWHAZ;CSTB;NTPCR;NOL8;MYH10;ISY1;LYAR;SAMSN1;NUDT1;HSPA9;RPL15;RANGAP1;NAF1;HLTF;DEK;SF3A2;HSPE1;MSI1;CDK11B;DDX11;LSM4;RBM38;RRP12;SNRPD2;EXOSC10;S100A16;MRPL16;MRPL23;RPL17;RPL23;XRN1;RPL34;CMSS1;OTUD4;DICER1;PUF60;SUCLG1;MRPL39;HNRNPLL;CDC5L;CCDC9B;RBM8A;RBMS2;RPS18;RTCB;GTF2E2;NUDT16;WDR75;DAZL;ZFP36L2;MECP2;TRMT2A;EXOSC9;NOC2L;CAPRIN1;APEH;THUMPD1;JMJD6;HNRNPM;ASS1;ELAVL2;XRN2;MRPL21;GCN1;NSUN6;GRWD1;NVL;XPOT;RBM15;RPL21;RDX;RADX;LRPPRC;HSD17B10;RPS4X;DDX54;ARL6IP4;EIF3H;RPP30;METTL3;RPL18A;NCBP1;HMGN5;PINX1;TXN;RPS21;NUP42;ZNF638;SUB1;RACK1;PEF1;DUSP11;RBM27
prerank,ADP binding (GO:0043531),-0.2752566529742942,-0.7653392222897227,0.8068459657701712,0.9866774602118714,1.0,2/25,4.11%,PRKAG2;ME1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.26036744136570256,0.7651337244636938,0.8446043165467626,1.0,1.0,14/73,16.82%,HCRTR1;APLNR;CALCRL;OXTR;SORCS1;NLRP6;HCRTR2;NPR1;CYSLTR1;ADCYAP1R1;RXFP3;RXFP2;OPRD1;GLP1R
prerank,Tat protein binding (GO:0030957),-0.3513562872527064,-0.7629674136150207,0.7673913043478261,0.9856526709483301,1.0,2/10,8.30%,MDFIC;SMARCB1
prerank,voltage-gated cation channel activity (GO:0022843),0.24475356601370035,0.7595803504930367,0.8704225352112676,1.0,1.0,14/97,12.88%,KCNH8;CACNA1A;KCNQ1;KCNC2;CACHD1;KCNG2;GRIN3B;KCNH2;KCNQ3;KCNV1;KCNA4;GRIN2B;KCNH7;HCN2
prerank,phosphatase activator activity (GO:0019211),0.3487873806383844,0.7593924230301906,0.7571428571428571,1.0,1.0,4/14,14.63%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,potassium channel activity (GO:0005267),0.2501802633887264,0.7590576759111567,0.8647482014388489,1.0,1.0,16/89,14.51%,KCNH8;KCNQ1;KCNC2;KCNK6;KCNG2;KCNH2;KCNN2;KCNQ3;KCNV1;KCNA4;KCNH7;GRIK5;GRIK2;HCN2;GRIK1;KCNF1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.34061378479085225,-0.7524484223534863,0.7979166666666667,0.9962189561788726,1.0,3/10,8.93%,FAP;NAALAD2;DPP4
prerank,C-C chemokine receptor activity (GO:0016493),0.3232291418461915,0.7524170803589468,0.7738693467336684,1.0,1.0,4/21,17.12%,CCR7;CXCR2;GPR75;CCR2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.25434170338143325,-0.7509270543846082,0.8474114441416893,0.9939935977252072,1.0,6/34,14.30%,FAM20A;CCNT2;IGF2;CAB39L;STRADA;DDX3X
prerank,CCR chemokine receptor binding (GO:0048020),0.30188115424629697,0.7493836855292689,0.8125,1.0,1.0,6/28,24.65%,NES;CCL1;CCR2;CCL25;CNIH4;NARS1
prerank,syntaxin binding (GO:0019905),0.2632035316445957,0.7477090567346601,0.8532110091743119,1.0,1.0,10/61,15.70%,CACNA1A;UNC13B;SYPL1;STXBP1;RAB11A;SYNPR;SNAP29;CPLX1;SYPL2;SCFD2
prerank,3'-5' DNA helicase activity (GO:0043138),0.33052332675211316,0.7468055331713741,0.7803163444639719,1.0,1.0,3/16,12.65%,NAV2;RECQL4;ASCC3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.34040652947992367,0.7447066586512421,0.7619926199261993,1.0,1.0,5/12,24.92%,STAT1;TNFSF11;TRAF3;TRAF6;TRAF1
prerank,histone methyltransferase activity (GO:0042054),-0.25308243091334764,-0.7426503646341726,0.875,1.0,1.0,10/32,20.69%,EHMT2;SMYD3;SETD7;PRMT5;PRMT8;KMT5B;EED;EZH2;SETD2;KMT5A
prerank,glycine binding (GO:0016594),0.3614113224552468,0.7425792517662558,0.7771639042357275,1.0,1.0,6/11,28.94%,GRIN3B;GRIN2B;GLRA2;GRIN1;GLRA1;GRIN3A
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.35433728368957385,0.7414121082934068,0.761384335154827,1.0,1.0,1/12,2.77%,NOD1
prerank,5'-nucleotidase activity (GO:0008253),0.3404021583278581,0.7399067180009367,0.7707581227436823,1.0,1.0,2/13,5.23%,NT5C3A;NT5C2
prerank,chemokine activity (GO:0008009),0.29330880541836063,0.7398804343768396,0.8302828618968386,1.0,1.0,1/31,1.41%,CXCL12
prerank,endopeptidase regulator activity (GO:0061135),-0.24325561047999783,-0.7381154653939087,0.8535211267605634,1.0,1.0,5/40,11.00%,TFPI;ITIH2;SERPIND1;RENBP;PSME3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.3021397273531813,-0.7375753614131053,0.806378132118451,0.9984504099975468,1.0,3/13,15.26%,GABRA3;GLRB;GABRE
prerank,sequence-specific mRNA binding (GO:1990825),-0.3376538618606964,-0.7374995861232727,0.7952069716775599,0.9941203169559095,1.0,3/10,22.46%,FMR1;LARP6;RBM24
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3162524348014517,-0.7370970848843156,0.8059360730593608,0.9902612134732667,1.0,5/12,16.82%,AOX1;SDHB;FXN;CISD2;FDX1
prerank,ligand-gated anion channel activity (GO:0099095),0.3146148757704238,0.7341611972856154,0.8133561643835616,1.0,1.0,9/17,25.86%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GABRA2;GLRA1;GABRG2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.32944928037220655,0.7324673072565441,0.7971781305114638,1.0,1.0,6/16,19.21%,INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,nuclease activity (GO:0004518),0.2588740085370205,0.7312247177496136,0.8662704309063893,1.0,1.0,13/52,18.00%,SAMHD1;NTHL1;MRE11;N4BP1;DFFB;DNA2;PDE12;RNASE1;RNASE12;SND1;ISG20L2;EXOG;ENDOG
prerank,GABA receptor activity (GO:0016917),0.29922703340246537,0.7312153980502446,0.7961335676625659,1.0,1.0,9/21,25.86%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABBR2;GABRA2;GABRG2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.3191109541676086,-0.7306267718653651,0.8095238095238095,0.9944758323104752,1.0,1/12,1.07%,B3GALT1
prerank,nucleosomal DNA binding (GO:0031492),-0.2750481791539249,-0.7297785200138495,0.8205741626794258,0.9912339603740189,1.0,6/21,18.14%,SMARCC2;SMARCB1;CHD4;MBD2;SMARCC1;RBBP4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.27244711157477264,0.7278357952116812,0.8427672955974843,1.0,1.0,13/42,24.77%,CCNY;CDKN2B;CCNI;CCND3;CCNK;CCNL2;CCNT1;KAT2B;CCNQ;CCNJL;INCA1;CDKN1B;CDKN2C
prerank,nucleotidase activity (GO:0008252),0.3245583416756167,0.7254433068404205,0.7823741007194245,1.0,1.0,2/15,5.23%,NT5C3A;NT5C2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.32383893398434777,-0.7253156119751538,0.8365180467091295,0.9926460477878493,1.0,2/11,14.36%,SLC5A3;SLC2A10
prerank,single-stranded telomeric DNA binding (GO:0043047),0.35347140542162026,0.7243254793367884,0.7782026768642447,1.0,1.0,5/11,29.29%,TERF2;TERF1;RPA1;NABP2;HNRNPA1
prerank,chemokine receptor binding (GO:0042379),0.27957814277242854,0.7232191480026511,0.8516129032258064,1.0,1.0,1/35,1.41%,CXCL12
prerank,inward rectifier potassium channel activity (GO:0005242),0.30521313720117704,0.7229998065932917,0.8169934640522876,1.0,1.0,7/24,18.39%,KCNK6;KCNH2;KCNN2;KCNN3;KCNJ3;KCNJ5;KCNJ6
prerank,cysteine-type peptidase activity (GO:0008234),-0.20695720046885002,-0.7227180748420573,0.9390681003584229,0.9914079177979321,1.0,30/73,29.21%,USP11;USP24;CTSL;USP40;USP2;ATG4A;OTULINL;CTSH;USP42;USP9X;CTSZ;CASP3;USP50;SFRP1;CASP6;CASP4;USP16;USP13;OTULIN;GGH;USP15;CASP9;USP10;USP37;USP36;USP20;USP47;USP9Y;USP1;USP33
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.3049050083068918,-0.7205899830223385,0.829004329004329,0.9896457258201169,1.0,3/13,11.20%,THUMPD3;TRMT10B;TRMT1L
prerank,ubiquitin binding (GO:0043130),-0.20847730134337286,-0.7180102565013206,0.9469964664310954,0.9885205504811204,1.0,23/73,24.38%,SMAD3;TSG101;PRKN;RNF31;OTULINL;AUP1;SIRT2;IKBKG;DNAJB2;USPL1;MVB12A;TOP2A;NBR1;USP16;USP13;ASCC2;RAE1;OTUB1;NEDD4;TOM1L1;UBAP1L;UBXN2A;UCHL3
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3049613864282408,0.7164690424438702,0.8172413793103448,1.0,1.0,4/21,13.66%,WASF2;KCNQ1;AKAP9;AKAP6
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.34137969631561993,0.7093853461836438,0.7624521072796935,1.0,1.0,3/11,13.40%,NAA60;NAA16;NAA11
prerank,thioesterase binding (GO:0031996),0.34056608442408903,0.7091686400958932,0.8,1.0,1.0,6/11,29.34%,RAC1;TRAF3;TRAF6;TRAF1;CDC42;TRAF2
prerank,ribosomal small subunit binding (GO:0043024),0.3139942370688909,0.7090277193415377,0.8253968253968254,1.0,1.0,10/17,28.37%,EIF4H;MTIF3;EIF1B;EIF4B;ABCE1;PIM1;ERAL1;PTCD3;EIF1;DHX29
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.19931991329353446,-0.7076137312584448,0.9771986970684039,0.9959003581199949,1.0,30/78,29.21%,USP11;USP24;CTSL;USP40;CASP12;USP2;CTSH;USP42;USP9X;CTSZ;CAPN1;CASP3;SFRP1;CASP6;CASP4;USP16;USP13;PYCARD;USP15;CASP9;CAPN15;USP10;USP37;USP36;USP20;USP47;USP9Y;USP1;GPAA1;USP33
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.24949754353057993,0.704722262699632,0.9063492063492063,1.0,1.0,5/54,5.12%,ACER2;HDAC9;TGM2;HINT1;ACER1
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.2758258209771099,-0.7038578926513287,0.8554216867469879,0.9957759520514586,1.0,12/17,46.74%,ACOT8;ACOT11;PLA2G6;THEM4;ACOT1;ACOT13;ACOT12;ACOT2;ACAA2;BAAT;ACOT4;ACOT7
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.3355098728115604,0.7036520897506051,0.7838345864661654,1.0,1.0,3/10,12.57%,CYBB;NCF4;NOX3
prerank,tau-protein kinase activity (GO:0050321),-0.26770054025068507,-0.703368225259856,0.8637469586374696,0.9922168067178183,1.0,2/20,5.88%,ROCK2;MARK1
prerank,chloride channel inhibitor activity (GO:0019869),0.34266186706372315,0.7002819190238603,0.7857142857142857,1.0,1.0,1/10,2.69%,STX1A
prerank,receptor antagonist activity (GO:0048019),-0.27854687422142316,-0.6987026309784147,0.8747044917257684,0.9929883959265338,1.0,1/17,1.64%,DKK3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.29239309547005954,0.6971892580550195,0.8480138169257341,1.0,1.0,2/22,3.63%,ATP2C1;ATP6V0A1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.31186348647683837,0.6970351124602591,0.811787072243346,1.0,1.0,1/16,5.35%,PIR
prerank,RNA cap binding (GO:0000339),0.30654279472758006,0.6950013211587253,0.835820895522388,1.0,1.0,7/16,22.19%,EIF3D;CYFIP1;NCBP2;EIF4E;EIF4A1;NCBP1;DCPS
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.27340404443577504,0.6944878188518062,0.8452768729641694,1.0,1.0,13/29,25.85%,PKIG;CDKN2B;PRKAR2B;PRKAR2A;HSPB1;RPTOR;KAT2B;INCA1;CDKN1B;SFN;CDKN2C;PRKAR1A;INKA2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3414676936535431,0.6939258272866475,0.8146788990825689,1.0,1.0,2/10,13.58%,ANKRD13A;FAN1
prerank,DNA polymerase binding (GO:0070182),0.30013051818036574,0.6919119173705438,0.8578680203045685,1.0,1.0,7/18,25.08%,HSP90AB1;ACD;POLG2;LONP1;PTGES3;NABP2;SMARCA4
prerank,UDP-galactosyltransferase activity (GO:0035250),0.336091891030876,0.684537477195717,0.8483245149911817,1.0,1.0,3/10,13.25%,B4GALT5;B3GALT4;B3GALT2
prerank,regulatory RNA binding (GO:0061980),-0.2244555433716601,-0.6831930311976343,0.9380053908355795,1.0,1.0,11/38,23.03%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;TARBP2;PIWIL2;SPOUT1;RBM10
prerank,glutathione transferase activity (GO:0004364),0.2826509768491514,0.6822965856496329,0.8643478260869565,1.0,1.0,4/23,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.24651123688656973,-0.6811368726372669,0.9112271540469974,1.0,1.0,8/27,26.27%,POLR2A;POLR3K;POLR1C;PRIMPOL;POLR2L;POLR1D;POLR3A;POLR2I
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.330539403225776,0.6802622265289179,0.8390151515151515,1.0,1.0,1/11,7.08%,CHRNB1
prerank,DNA replication origin binding (GO:0003688),0.28716663470915205,0.6783087107628413,0.8647686832740213,1.0,1.0,6/23,21.01%,MCM10;CDC6;ORC1;DDX11;GRWD1;POLA1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3072158594727349,-0.6781351767480849,0.8358531317494601,1.0,1.0,5/10,23.23%,CASP12;CASP3;CASP6;CASP4;CASP9
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.24599850515077798,-0.6770217053517756,0.9057591623036649,0.9982715733748976,1.0,8/27,26.27%,POLR2A;TENT2;POLR3K;POLR1C;POLR2L;POLR1D;POLR3A;POLR2I
prerank,P-type ion transporter activity (GO:0015662),0.3188994158207608,0.6763188461203277,0.8389380530973451,1.0,1.0,2/12,6.35%,ATP2C1;ATP2B1
prerank,thyroid hormone receptor binding (GO:0046966),-0.2352081101725303,-0.6745221936454818,0.9213759213759214,0.9962339502900976,1.0,11/28,27.31%,HMGN3;BRD8;TRIP12;MED30;NCOR1;NSD1;MED4;GTF2H1;MED24;MED16;PRMT2
prerank,sodium channel regulator activity (GO:0017080),-0.22213778281249227,-0.6706910530909318,0.9516908212560387,0.9955690638189728,1.0,3/37,3.85%,PTPN3;SNTA1;CAMK2D
prerank,hormone activity (GO:0005179),-0.200654334083595,-0.6673053313870438,0.9761194029850746,0.994336110240061,1.0,1/54,0.34%,IGF1
prerank,damaged DNA binding (GO:0003684),-0.21509545823823675,-0.6653336976625833,0.9669421487603306,0.9920235309932111,1.0,22/44,36.19%,RBBP8;TDG;DDB2;SMC6;CRY2;XRCC1;EP300;SDE2;ERCC1;CUL4B;NBN;HMGB1;CREBBP;ERCC2;NEIL3;APEX1;FEN1;RAD18;AUNIP;UNG;DCLRE1A;ERCC5
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3195740665034017,0.6632617394071728,0.846551724137931,1.0,1.0,6/11,22.19%,NUDT3;DCP2;NUDT1;NUDT10;NUDT16;DCPS
prerank,kinesin binding (GO:0019894),0.2631374327889908,0.6588529430459178,0.904610492845787,1.0,1.0,6/27,17.73%,ACTB;CLSTN1;SPAG9;AP1G1;AP1AR;ARHGEF10
prerank,snoRNA binding (GO:0030515),-0.2200005665953826,-0.6532874554021302,0.9611111111111111,0.9974032340332325,1.0,5/30,16.69%,NUDT4;NOP14;XRCC5;GAR1;NOP56
prerank,carboxypeptidase activity (GO:0004180),0.2539757179489034,0.6528126642482514,0.9199346405228758,1.0,1.0,5/35,10.49%,MINDY1;VASH1;CPD;AGBL5;MINDY2
prerank,NADP binding (GO:0050661),0.2510306879719758,0.6519951983229867,0.9241935483870968,1.0,1.0,6/32,14.82%,NOS3;NOS2;CAT;HMGCR;LBR;QDPR
prerank,C-C chemokine binding (GO:0019957),0.27577378575553774,0.6496980574210676,0.9006622516556292,1.0,1.0,2/22,8.20%,CCR7;CXCR2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2774727552822649,-0.649133560376047,0.9043280182232346,0.9964832049253942,1.0,4/14,17.41%,SDHB;ACO1;RSAD1;NDUFS1
prerank,magnesium ion binding (GO:0000287),0.20033829033744108,0.6428582235466411,0.9856020942408377,1.0,1.0,36/135,22.51%,PDE2A;STK38;SNRK;HPRT1;NT5C3A;MTPAP;PRKACB;IDH3A;MAP3K6;PDXK;HPGDS;NUDT3;DXO;CERK;STK3;FAN1;HACL1;XYLT2;MOV10L1;PDCD6;STK26;MSH2;NLRC4;SIK2;CIB2;TPPP;ADPRS;PGP;NUDT16;MAP2K7;BRSK2;MAST1;SNCA;SIK3;PAPOLA;CDC42BPA
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.30482837705560567,0.6401474621991146,0.8838475499092558,1.0,1.0,3/12,20.49%,SLC25A5;SLC35B3;SLC25A23
prerank,E-box binding (GO:0070888),0.24497997587446646,0.6391589299474936,0.940032414910859,1.0,1.0,5/34,12.84%,TAL1;SNAI2;MAX;CIART;PPARG
prerank,protein kinase activator activity (GO:0030295),0.22338973916956903,0.6383135674732597,0.9631811487481591,1.0,1.0,6/60,8.39%,AFAP1L2;RGCC;FGF13;CALM1;IRGM;IQGAP1
prerank,calcium-activated potassium channel activity (GO:0015269),0.30844749454618064,0.6380130770106741,0.8683206106870229,1.0,1.0,2/11,8.25%,KCNN2;KCNN3
prerank,GDP binding (GO:0019003),-0.18792687552449888,-0.6356431693725756,0.984375,1.0,1.0,18/63,24.92%,ARL3;TRIM23;RAB21;MRAS;RASL12;MIEF1;RHEB;RIT1;RAB29;GNAI3;RAB11B;RAB22A;RAB14;RERG;RAP2A;RAB9A;RAP2C;RASEF
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.2857964110955793,-0.6354224328284438,0.9164835164835164,0.998973987286041,1.0,2/10,15.26%,GABRA3;GABRE
prerank,beta-tubulin binding (GO:0048487),0.2521479900193549,0.6306497494779986,0.9191419141914191,1.0,1.0,4/31,10.99%,TTLL7;FGF13;CCT5;PEX14
prerank,deoxyribonuclease activity (GO:0004536),0.2862430386886504,0.6270994882617575,0.8978805394990366,1.0,1.0,2/14,9.03%,MRE11;DFFB
prerank,rRNA binding (GO:0019843),-0.19934427848147088,-0.6250991280536163,0.9710526315789474,1.0,1.0,13/42,27.08%,MRPS27;MTERF4;PPAN;EMG1;RCC1L;UTP23;CIRBP;MRPS6;MRPL18;FASTKD2;ERI1;RPS5;NOP53
prerank,mannose binding (GO:0005537),-0.2713660487980941,-0.6247058767812644,0.9201680672268907,0.9981669302361303,1.0,9/12,52.27%,LMAN1;LMAN2L;COLEC11;LMAN2;CLEC4D;ACR;CLEC6A;CD207;LMAN1L
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.23054665984727465,-0.6220173794920675,0.9443099273607748,0.9959939701349454,1.0,8/22,22.16%,IKBKE;ZRANB3;ZBTB1;IKBKG;OPTN;ATRIP;WDR81;TAB3
prerank,four-way junction DNA binding (GO:0000400),0.27507356141875994,0.6187134842101594,0.9081272084805654,1.0,1.0,3/17,15.56%,MEN1;HMGB2;MSH2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.29979535331011836,0.6171973648117884,0.8776595744680851,1.0,1.0,2/10,13.58%,ANKRD13A;FAN1
prerank,phospholipase A2 activity (GO:0004623),0.24560319142028247,0.6168847310461237,0.9435897435897436,1.0,1.0,3/26,14.91%,PLA2G4B;PNPLA8;PRDX6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.2677365002031264,-0.6123443278523698,0.9020044543429844,0.9980473550773367,1.0,3/11,26.28%,SLC25A24;SLC35B2;SLC25A42
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.26900389318068874,-0.6116969565543853,0.9337606837606838,0.9945673810411206,1.0,3/11,14.99%,PRMT5;PRMT8;PRMT9
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.24446258595186388,0.6113596429867723,0.9490131578947368,1.0,1.0,7/34,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.24446258595186388,0.6113596429867723,0.9490131578947368,1.0,1.0,7/34,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,pyrophosphatase activity (GO:0016462),0.21670406030288802,0.6106479188628676,0.9701046337817638,1.0,1.0,12/50,22.31%,ENTPD1;ENTPD5;NUDT3;DCP2;DXO;NUDT9;DOLPP1;NUDT1;NUDT10;NUDT16;DCPS;BNIP2
prerank,tRNA binding (GO:0000049),-0.19821665496903307,-0.6063246681770775,0.9823529411764705,0.9936289560466712,1.0,20/43,30.77%,TRMT9B;DALRD3;MRPS27;TRMT10B;NSUN2;ALKBH1;ELP5;IGHMBP2;EIF2A;RPUSD4;DARS2;TYW5;FARS2;TRNAU1AP;AIMP1;SEPSECS;PTCD1;KARS1;TERT;CTU1
prerank,ferrous iron binding (GO:0008198),-0.22738135834287984,-0.6037723350296427,0.9574468085106383,0.9910928538273253,1.0,4/21,12.53%,EGLN3;FXN;PHYH;ALKBH1
prerank,neuropeptide binding (GO:0042923),0.26791588462421967,0.6024262966079192,0.9114583333333334,1.0,1.0,4/18,25.80%,OPRD1;SSTR1;OPRM1;GPR149
prerank,RNA polymerase binding (GO:0070063),-0.23473943219145138,-0.6010303418960663,0.9407894736842105,0.9886151052878721,1.0,5/18,22.12%,CCNT2;PABPN1;BRCA1;TCERG1;NEDD4
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2172110145415192,-0.5985430557442716,0.9630484988452656,0.9860565478325861,1.0,10/24,28.92%,IGF2BP2;FMR1;DDX3X;LARP6;UTP23;NCL;SHMT1;SYNCRIP;IGF2BP1;DHX36
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2579829951231545,0.5982123928780646,0.9439728353140917,1.0,1.0,3/21,12.88%,CHRNB1;P2RX7;GRIK2
prerank,omega peptidase activity (GO:0008242),0.19637513056121544,0.5978725901391737,0.9915966386554622,1.0,1.0,22/89,20.20%,USP53;ATXN3;OTUD7A;MYSM1;PAN2;USP18;ASRGL1;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1;APEH
prerank,ribonuclease P RNA binding (GO:0033204),0.2923135509765008,0.5972303607993302,0.9220532319391636,1.0,1.0,3/10,21.47%,RPP38;RPP21;RPP30
prerank,U6 snRNA binding (GO:0017070),0.2732958816126962,0.5964354263628259,0.9281867145421903,1.0,1.0,5/14,25.82%,EIF5A;PRPF4;LSM4;PRPF8;SART3
prerank,exonuclease activity (GO:0004527),0.21948555616018245,0.5960768639520225,0.9636913767019667,1.0,1.0,16/46,22.45%,MRE11;ENPP2;PDE12;CNOT6;DXO;FAN1;TRIR;ISG20L2;EXOG;REV3L;EXOSC10;EXOSC9;XRN2;RAD1;DCLRE1C;EXOSC8
prerank,thiol-dependent deubiquitinase (GO:0004843),0.1982866307544134,0.5953795067368862,0.9914407988587732,1.0,1.0,20/83,20.14%,USP53;ATXN3;OTUD7A;MYSM1;PAN2;USP18;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.22760672928403647,-0.5918377113574816,0.9601990049751243,0.9855601647435893,1.0,10/20,31.45%,SENP3;OTULINL;USP9X;USP50;OTUB1;SENP5;OTUD5;USP47;YOD1;UFSP2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2147759941976114,0.5911424365906506,0.9759398496240601,1.0,1.0,18/57,27.63%,NDUFA2;NDUFA8;NDUFA4;CYB561A3;UQCRC1;NDUFA12;NDUFB3;NDUFC1;UQCRQ;COX10;UQCR11;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.2429419705988108,-0.5900283341629682,0.9230769230769231,0.9827085772092946,1.0,5/14,22.48%,NOX4;CYBA;MICAL1;KMO;NOX1
prerank,single-stranded RNA binding (GO:0003727),0.21626066832208563,0.5796099080971964,0.9792,1.0,1.0,15/43,27.14%,IFIH1;EIF4H;TLR7;SNRPC;TLR8;AQR;DDX11;EXOSC10;JMJD6;EIF4B;ADARB2;LONP1;DDX60;HNRNPF;AGO1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.25851608891574884,0.5768388679055577,0.9288194444444444,1.0,1.0,2/15,7.17%,SNX3;PLEKHA5
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2654677549217158,0.5733369218938718,0.9492753623188406,1.0,1.0,4/13,24.16%,DNA2;FAN1;DICER1;GEN1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2192477011480419,-0.573125283886515,0.9633867276887872,0.9864876966555641,1.0,5/20,15.96%,RBBP8;ENDOV;ZRANB3;ERCC1;RAD50
prerank,endonuclease activity (GO:0004519),0.20601870361314994,0.5717138488682219,0.9770992366412213,1.0,1.0,16/49,27.15%,NTHL1;PIWIL1;MRE11;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;ERCC4;KHNYN;ZC3H12A;PNKP;AGO1;ENDOU
prerank,microtubule plus-end binding (GO:0051010),0.23844441352829887,0.5661292899815785,0.9467353951890034,1.0,1.0,7/20,21.14%,CLIP1;MAPRE2;MAPRE3;APC;CLIP2;DCTN1;CLASP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.23501461516243097,0.5648571782008449,0.9515859766277128,1.0,1.0,4/22,19.35%,MESD;AP2M1;DNAJA1;LRPAP1
prerank,neuropeptide receptor activity (GO:0008188),0.22169337271142286,0.5589242953221298,0.967266775777414,1.0,1.0,7/29,25.66%,SORCS1;HCRTR2;NPY5R;SSTR1;GRPR;OPRM1;SORCS3
prerank,snRNA binding (GO:0017069),0.2075380024888577,0.5541824974392568,0.9922239502332815,1.0,1.0,13/42,25.82%,EFTUD2;SNU13;SNRPC;EIF5A;NCBP2;PRPF4;SNRPB2;LSM4;CCNT1;SF3B3;PRPF8;SNRPA;SART3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.26807387310612396,0.5517328197587434,0.9367816091954023,1.0,1.0,2/11,16.58%,NTHL1;HMGA2
prerank,endoribonuclease activity (GO:0004521),0.2159425184753483,0.5512541338738404,0.9667721518987342,1.0,1.0,13/32,27.15%,PIWIL1;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;RIDA;KHNYN;ZC3H12A;AGO1;ENDOU
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23729514028522725,0.5510160456730104,0.9652777777777778,1.0,1.0,3/18,21.07%,HSD17B7;HSD17B8;HSD17B10
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2520298715114452,0.5451495552184652,0.9546279491833031,1.0,1.0,5/14,19.21%,MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2268876678585394,-0.5439734796932538,0.9667458432304038,0.9932835601519374,1.0,2/15,9.43%,P2RX4;P2RY14
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2199917676874386,0.5416162182041836,0.9699499165275459,1.0,1.0,8/28,21.47%,EDC3;ELAC1;RPP38;MRPL44;RPP21;DICER1;NUDT16;RPP30
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.20594008238208694,0.5352791179885701,0.978405315614618,1.0,1.0,9/35,21.25%,NT5C3A;PTRH2;ELAC1;DTWD2;GATC;TRMT12;MRPL58;TRMT5;QTRT2
prerank,acetylcholine receptor activity (GO:0015464),0.22190096263749537,0.5343662473575275,0.9625668449197861,1.0,1.0,2/22,10.93%,CHRNB1;CHRM3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.19956631653927528,0.5243672227930823,0.9887820512820513,1.0,1.0,14/37,28.47%,SARS1;SARS2;YARS2;GARS1;TARS3;FARSB;PARS2;CARS1;NARS1;IARS2;HARS1;VARS1;MARS2;LARS2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2596033140848608,0.521823408076902,0.9467889908256881,1.0,1.0,10/10,74.06%,POLD1;DCLRE1C;EXD2;DCLRE1B;MGME1;DCLRE1A;FEN1;APEX1;TATDN1;EXO1
prerank,telomeric DNA binding (GO:0042162),0.20175837266512175,0.5160097505577184,0.9744408945686901,1.0,1.0,4/32,12.47%,HMBOX1;TERF2;ACD;TERF1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2138684755982665,0.5130318395980986,0.9730700179533214,1.0,1.0,21/21,78.64%,CHRNB1;GRM5;GRIA1;GRM1;CHRNA2;CHRNA6;DRD4;DRD1;CHRNA1;DRD5;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5;CHRNA7;CHRFAM7A;CHRNB2;CHRNA4;ANXA9
prerank,nuclear import signal receptor activity (GO:0061608),-0.20785428089785443,-0.5019908186630704,0.9839080459770115,1.0,1.0,5/15,26.85%,KPNA3;KPNB1;HIKESHI;KPNA6;KPNA1
prerank,myosin V binding (GO:0031489),0.22636745468171324,0.49573092443148586,0.9772727272727273,1.0,1.0,2/15,10.48%,RAB11A;RAB3B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2197835338791294,0.4946800420518078,0.972972972972973,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2197835338791294,0.4946800420518078,0.972972972972973,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,androgen receptor binding (GO:0050681),0.20054339946575833,0.4896723369035265,0.9847972972972973,1.0,1.0,13/25,29.82%,PKN1;PRKCB;ZBTB7A;TRIM68;FOXP1;KDM3A;DAXX;CALR;SMARCA4;SNW1;KDM4C;PARK7;PRPF6
prerank,NADPH binding (GO:0070402),0.2254356467447734,0.47970059543256954,0.9716981132075472,1.0,1.0,3/13,14.82%,HMGCR;LBR;QDPR
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.21107632612242433,0.4707321528040788,0.977859778597786,1.0,1.0,4/15,24.41%,PRDM9;KMT2C;RBBP5;WDR82
prerank,O-methyltransferase activity (GO:0008171),0.22794644984305124,0.4662690233684242,0.985239852398524,1.0,1.0,3/10,21.16%,CMTR2;CMTR1;COQ3
prerank,tRNA methyltransferase activity (GO:0008175),0.20816135185756668,0.4637533054834011,0.993103448275862,1.0,1.0,7/16,26.66%,TRMT12;METTL2A;METTL2B;ALKBH8;TRMT5;TARBP1;TYW3
prerank,G protein-coupled amine receptor activity (GO:0008227),0.19451621781486367,0.4609429394281601,0.9929577464788732,0.9994494808639756,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,serotonin receptor activity (GO:0099589),0.19451621781486367,0.4609429394281601,0.9929577464788732,0.9994494808639756,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.19451621781486367,0.4609429394281601,0.9929577464788732,0.9994494808639756,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,methyltransferase activity (GO:0008168),0.1656733349242043,0.4548962730266972,1.0,0.9981017731535665,1.0,15/46,28.30%,LCMT1;EEF1AKMT3;NDUFAF7;MGMT;MRM2;COMTD1;PRMT7;COQ3;METTL3;GCSH;TRMT11;EEF1AKMT4;SUV39H1;DNMT1;DNMT3B
prerank,RNA methyltransferase activity (GO:0008173),-0.1717429778729982,-0.4449452969482407,0.997737556561086,1.0,1.0,2/19,9.03%,TRMT9B;TGS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.1735308890005023,-0.427849430546007,0.9912472647702407,1.0,1.0,14/14,82.67%,CAPN1;CAPN15;CAPN11;CAPN5;CAPN8;CAPN3;CAPNS2;CAPN9;CAPN13;CAPN6;CAPNS1;CAPN10;CAPN12;CAPN2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.17665582999185925,-0.4249231571108308,0.9934354485776805,1.0,1.0,3/14,19.15%,PRORP;POP4;TSEN2
prerank,cytochrome-c oxidase activity (GO:0004129),0.18389377474358376,0.40519011191766363,0.9892280071813285,1.0,1.0,7/15,31.46%,NDUFA4;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,ribonuclease P activity (GO:0004526),0.1871107871664403,0.3924730229086602,1.0,1.0,1.0,3/11,21.47%,RPP38;RPP21;RPP30
prerank,proton transmembrane transporter activity (GO:0015078),-0.12549873186088656,-0.3876677382946871,1.0,0.9991413469330102,1.0,9/39,24.58%,SLC9A1;COX6A1;UQCRFS1;SLC33A1;NNT;ATP6V1F;COX6B1;CLCN4;SLC11A2
prerank,single-stranded DNA helicase activity (GO:0017116),0.14030019468693083,0.3213242632268203,1.0,0.9998578111447625,1.0,19/19,85.99%,DNA2;CHTF18;RFC2;RFC4;WRNIP1;MCM6;HELQ;DHX9;RAD51;MCM7;MCM2;CHTF8;POLQ;PIF1;DSCC1;RFC5;MCM5;RFC3;HELB
